{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:00:44Z","timestamp":1757617244886,"version":"3.44.0"},"publisher-location":"Cham","reference-count":490,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031993732"},{"type":"electronic","value":"9783031993749"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/16833_2024_369","type":"book-chapter","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T10:01:54Z","timestamp":1728727314000},"page":"361-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Telomere Maintenance Mechanisms in Cancer"],"prefix":"10.1007","author":[{"given":"Tito Teles","family":"Jesus","sequence":"first","affiliation":[]},{"given":"Rui Sousa","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Tiago Bordeira","family":"Gaspar","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Vinagre","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,10,13]]},"reference":[{"key":"369_CR1","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/modpathol.2013.90","volume":"26","author":"M Abedalthagafi","year":"2013","unstructured":"Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, Croul SE, Santi MR, Cheng J, Zhou S, Sullivan LM, Martinez-Lage M, Judkins AR, Perry A (2013) The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Mod Pathol 26:1425\u20131432","journal-title":"Mod Pathol"},{"key":"369_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/ERC-16-0421","volume":"24","author":"S Ahn","year":"2017","unstructured":"Ahn S, Kim TH, Kim SW, Ki CS, Jang HW, Kim JS, Kim JH, Choe JH, Shin JH, Hahn SY, Oh YL, Chung JH (2017) Comprehensive screening for PD-L1 expression in thyroid cancer. Endocr Relat Cancer 24:97\u2013106","journal-title":"Endocr Relat Cancer"},{"key":"369_CR3","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1002\/cncr.31754","volume":"124","author":"TV Ahvenainen","year":"2018","unstructured":"Ahvenainen TV, M\u00e4kinen NM, von Nandelstadh P, Vahteristo MEA, Pasanen AM, B\u00fctzow RC, Vahteristo PM (2018) Loss of ATRX\/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas. Cancer 124:4650\u20134656","journal-title":"Cancer"},{"key":"369_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/1541-7786.MCR-18-0359","volume":"17","author":"M Alexiadis","year":"2019","unstructured":"Alexiadis M, Rowley SM, Chu S, Leung DTH, Stewart CJR, Amarasinghe KC, Campbell IG, Fuller PJ (2019) Mutational landscape of ovarian adult granulosa cell tumors from whole exome and targeted TERT promoter sequencing. Mol Cancer Res 17:177\u2013185","journal-title":"Mol Cancer Res"},{"key":"369_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/path.5110","volume":"246","author":"C Alidousty","year":"2018","unstructured":"Alidousty C, Baar T, Martelotto LG, Heydt C, Wagener S, Fassunke J, Duerbaum N, Scheel AH, Frank S, Holz B, Binot E, Kron A, Merkelbach-Bruse S, Ihle MA, Wolf J, Buettner R, Schultheis AM (2018) Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations. J Pathol 246:67\u201376","journal-title":"J Pathol"},{"key":"369_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","volume":"65","author":"Y Allory","year":"2014","unstructured":"Allory Y, Beukers W, Sagrera A, Flandez M, Marques M, Marquez M, van der Keur KA, Dyrskjot L, Lurkin I, Vermeij M, Carrato A, Lloreta J, Lorente JA, Carrillo-de Santa Pau E, Masius RG, Kogevinas M, Steyerberg EW, van Tilborg AA, Abas C, Orntoft TF, Zuiverloon TC, Malats N, Zwarthoff EC, Real FX (2014) Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol 65:360\u2013366","journal-title":"Eur Urol"},{"key":"369_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/thy.2015.0510","volume":"26","author":"AS Alzahrani","year":"2016","unstructured":"Alzahrani AS, Qasem E, Murugan AK, Al-Hindi HN, AlKhafaji D, Almohanna M, Xing M, Alhomaidah D, AlSwailem M (2016) Uncommon TERT promoter mutations in pediatric thyroid cancer. Thyroid 26:235\u2013241","journal-title":"Thyroid"},{"key":"369_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/genes7090066","volume":"7","author":"JP Amorim","year":"2016","unstructured":"Amorim JP, Santos G, Vinagre J, Soares P (2016) The role of ATRX in the alternative lengthening of telomeres (ALT) phenotype. Genes (Basel) 7:66","journal-title":"Genes (Basel)"},{"key":"369_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bjc.6603253","volume":"95","author":"S Andersson","year":"2006","unstructured":"Andersson S, Wallin KL, Hellstrom AC, Morrison LE, Hjerpe A, Auer G, Ried T, Larsson C, Heselmeyer-Haddad K (2006) Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer 95:331\u2013338","journal-title":"Br J Cancer"},{"key":"369_CR10","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2353\/ajpath.2009.090122","volume":"175","author":"S Andersson","year":"2009","unstructured":"Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, Gravitt PE, Larsson C, Wallin KL, Ried T, Heselmeyer-Haddad K (2009) Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. Am J Pathol 175:1831\u20131847","journal-title":"Am J Pathol"},{"key":"369_CR11","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/ijc.31412","volume":"143","author":"C Annunziata","year":"2018","unstructured":"Annunziata C, Pezzuto F, Greggi S, Ionna F, Losito S, Botti G, Buonaguro L, Buonaguro FM, Tornesello ML (2018) Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma. Int J Cancer 143:1153\u20131161","journal-title":"Int J Cancer"},{"key":"369_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-013-1141-6","volume":"126","author":"H Arita","year":"2013","unstructured":"Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K (2013a) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126:267\u2013276","journal-title":"Acta Neuropathol"},{"key":"369_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00401-013-1203-9","volume":"126","author":"H Arita","year":"2013","unstructured":"Arita H, Narita Y, Takami H, Fukushima S, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Shibui S, Ichimura K (2013b) TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas. Acta Neuropathol 126:939\u2013941","journal-title":"Acta Neuropathol"},{"key":"369_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-016-0351-2","volume":"4","author":"H Arita","year":"2016","unstructured":"Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H, Tanaka S, Mukasa A, Shirahata M, Shimizu S, Suzuki K, Saito K, Kobayashi K, Higuchi F, Uzuka T, Otani R, Tamura K, Sumita K, Ohno M, Miyakita Y, Kagawa N, Hashimoto N, Hatae R, Yoshimoto K, Shinojima N, Nakamura H, Kanemura Y, Okita Y, Kinoshita M, Ishibashi K, Shofuda T, Kodama Y, Mori K, Tomogane Y, Fukai J, Fujita K, Terakawa Y, Tsuyuguchi N, Moriuchi S, Nonaka M, Suzuki H, Shibuya M, Maehara T, Saito N, Nagane M, Kawahara N, Ueki K, Yoshimine T, Miyaoka E, Nishikawa R, Komori T, Narita Y, Ichimura K (2016) A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun 4:79","journal-title":"Acta Neuropathol Commun"},{"key":"369_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO;2-3","volume":"16","author":"N Arnold","year":"1996","unstructured":"Arnold N, H\u00e4gele L, Walz L, Schempp W, Pfisterer J, Bauknecht T, Kiechle M (1996) Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16:46\u201354","journal-title":"Genes Chromosomes Cancer"},{"key":"369_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nsmb.3092","volume":"22","author":"N Arnoult","year":"2015","unstructured":"Arnoult N, Karlseder J (2015) Complex interactions between the DNA-damage response and mammalian telomeres. Nat Struct Mol Biol 22:859\u2013866","journal-title":"Nat Struct Mol Biol"},{"key":"369_CR17","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/ncomms6220","volume":"5","author":"R Arora","year":"2014","unstructured":"Arora R, Lee Y, Wischnewski H, Brun CM, Schwarz T, Azzalin CM (2014) RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nat Commun 5:5220","journal-title":"Nat Commun"},{"key":"369_CR18","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1158\/0008-5472.CAN-05-1715","volume":"65","author":"SP Atkinson","year":"2005","unstructured":"Atkinson SP, Hoare SF, Glasspool RM, Keith WN (2005) Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 65:7585\u20137590","journal-title":"Cancer Res"},{"key":"369_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-12-397898-1.00004-9","volume":"125","author":"G Aubert","year":"2014","unstructured":"Aubert G (2014) Telomere dynamics and aging. Prog Mol Biol Transl Sci 125:89\u2013111","journal-title":"Prog Mol Biol Transl Sci"},{"key":"369_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jmr.2521","volume":"29","author":"D Azhibek","year":"2016","unstructured":"Azhibek D, Skvortsov D, Andreeva A, Zatsepin T, Arutyunyan A, Zvereva M, Dontsova O (2016) TERRA mimicking ssRNAs prevail over the DNA substrate for telomerase in vitro due to interactions with the alternative binding site. J Mol Recognit 29:242\u2013247","journal-title":"J Mol Recognit"},{"key":"369_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1126\/science.1147182","volume":"318","author":"CM Azzalin","year":"2007","unstructured":"Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J (2007) Telomeric repeat-containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318:798\u2013801","journal-title":"Science"},{"key":"369_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13000-016-0458-6","volume":"11","author":"JS Bae","year":"2016","unstructured":"Bae JS, Kim Y, Jeon S, Kim SH, Kim TJ, Lee S, Kim MH, Lim DJ, Lee YS, Jung CK (2016) Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation. Diagn Pathol 11:21","journal-title":"Diagn Pathol"},{"key":"369_CR23","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/modpathol.2016.126","volume":"29","author":"A Bahrami","year":"2016","unstructured":"Bahrami A, Lee S, Schaefer IM, Boland JM, Patton KT, Pounds S, Fletcher CD (2016) TERT promoter mutations and prognosis in solitary fibrous tumor. Mod Pathol 29:1511\u20131522","journal-title":"Mod Pathol"},{"key":"369_CR24","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1158\/1078-0432.CCR-17-0980","volume":"23","author":"X Bai","year":"2017","unstructured":"Bai X, Kong Y, Chi Z, Sheng X, Cui C, Wang X, Mao L, Tang B, Li S, Lian B, Yan X, Zhou L, Dai J, Guo J, Si L (2017) MAPK pathway and TERT promoter gene mutation pattern and its prognostic value in melanoma patients: a retrospective study of 2,793 cases. Clin Cancer Res 23:6120\u20136127","journal-title":"Clin Cancer Res"},{"key":"369_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.4103\/0028-3886.349649","volume":"70","author":"S Balakumar","year":"2022","unstructured":"Balakumar S, Pai R, Chacko AG, Patel B, Nancy R, Balakrishnan R, Sarkar S, Sampath G, Chacko G (2022) Telomerase reverse transcriptase promoter mutations in a cohort of adult gliomas \u2013 clinicopathological correlates. Neurol India 70:953\u2013959","journal-title":"Neurol India"},{"key":"369_CR26","first-page":"2116","volume":"57","author":"BR Balsara","year":"1997","unstructured":"Balsara BR, Sonoda G, Du Manoir S, Siegfried JM, Gabrielson E, Testa JR (1997) Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57:2116\u20132120","journal-title":"Cancer Res"},{"key":"369_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fendo.2020.00269","volume":"11","author":"MC Barros-Filho","year":"2020","unstructured":"Barros-Filho MC, de Mello JBH, Marchi FA, Pinto CAL, da Silva IC, Damasceno PKF, Soares MBP, Kowalski LP, Rogatto SR (2020) GADD45B transcript is a prognostic marker in papillary thyroid carcinoma patients treated with total thyroidectomy and radioiodine therapy. Front Endocrinol (Lausanne) 11:269","journal-title":"Front Endocrinol (Lausanne)"},{"key":"369_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215\u2013233","journal-title":"Cell"},{"key":"369_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng.3781","volume":"49","author":"FP Barthel","year":"2017","unstructured":"Barthel FP, Wei W, Tang M, Martinez-Ledesma E, Hu X, Amin SB, Akdemir KC, Seth S, Song X, Wang Q, Lichtenberg T, Hu J, Zhang J, Zheng S, Verhaak RG (2017) Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nat Genet 49:349\u2013357","journal-title":"Nat Genet"},{"key":"369_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/ijc.30057","volume":"139","author":"R Batista","year":"2016","unstructured":"Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Maximo V, Soares P, Sobrinho-Simoes M, Reis RM, Lima J (2016) The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism. Int J Cancer 139:414\u2013423","journal-title":"Int J Cancer"},{"key":"369_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0301-472X(01)00760-3","volume":"30","author":"OE Bechter","year":"2002","unstructured":"Bechter OE, Eisterer W, Dlaska M, Kuhr T, Thaler J (2002) CpG Island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. Exp Hematol 30:26\u201333","journal-title":"Exp Hematol"},{"key":"369_CR32","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899","journal-title":"Nature"},{"key":"369_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11060-018-2912-7","volume":"139","author":"A Biczok","year":"2018","unstructured":"Biczok A, Kraus T, Suchorska B, Terpolilli NA, Thorsteinsdottir J, Giese A, Tonn JC, Schichor C (2018) TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas. J Neuro-Oncol 139:671\u2013678","journal-title":"J Neuro-Oncol"},{"key":"369_CR34","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.annonc.2021.09.004","volume":"32","author":"P Billard","year":"2021","unstructured":"Billard P, Guerriau C, Carpentier C, Juillard F, Grandin N, Lomonte P, Kantapareddy P, Dufay N, Barritault M, Rimokh R, Verrelle P, Maucort-Boulch D, Figarella-Branger D, Ducray F, Dehais C, Charbonneau M, Meyronet D, Poncet DA (2021) The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches. Ann Oncol 32:1608\u20131617","journal-title":"Ann Oncol"},{"key":"369_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.02.011","volume":"173","author":"S Biswas","year":"2017","unstructured":"Biswas S, Rao CM (2017) Epigenetics in cancer: fundamentals and beyond. Pharmacol Ther 173:118\u2013134","journal-title":"Pharmacol Ther"},{"key":"369_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<79::AID-GCC11>3.0.CO;2-D","volume":"22","author":"A-M Bj\u00f6rkqvist","year":"1998","unstructured":"Bj\u00f6rkqvist A-M, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Tammilehto L, Mattson K, Vainio H, Knuutila S (1998) DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer 22:79\u201382","journal-title":"Genes Chromosomes Cancer"},{"key":"369_CR37","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/nm1006-1133","volume":"12","author":"EH Blackburn","year":"2006","unstructured":"Blackburn EH, Greider CW, Szostak JW (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12:1133","journal-title":"Nat Med"},{"key":"369_CR38","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.aab3389","volume":"350","author":"EH Blackburn","year":"2015","unstructured":"Blackburn EH, Epel ES, Lin J (2015) Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science 350:1193\u20131198","journal-title":"Science"},{"key":"369_CR39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/carcin\/bgh185","volume":"25","author":"MA Blasco","year":"2004","unstructured":"Blasco MA (2004) Telomere epigenetics: a higher-order control of telomere length in mammalian cells. Carcinogenesis 25:1083\u20131087","journal-title":"Carcinogenesis"},{"key":"369_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrg1656","volume":"6","author":"MA Blasco","year":"2005","unstructured":"Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6:611\u2013622","journal-title":"Nat Rev Genet"},{"key":"369_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrg2047","volume":"8","author":"MA Blasco","year":"2007","unstructured":"Blasco MA (2007) The epigenetic regulation of mammalian telomeres. Nat Rev Genet 8:299\u2013309","journal-title":"Nat Rev Genet"},{"key":"369_CR42","first-page":"5325","volume":"56","author":"U Bockm\u00fchl","year":"1996","unstructured":"Bockm\u00fchl U, Schwendel A, Dietel M, Petersen I (1996) Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res 56:5325\u20135329","journal-title":"Cancer Res"},{"key":"369_CR43","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1126\/science.1260200","volume":"347","author":"S Borah","year":"2015","unstructured":"Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB, Costello JC, Theodorescu D, Cech TR (2015) Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science 347:1006\u20131010","journal-title":"Science"},{"key":"369_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00432-020-03130-z","volume":"146","author":"P Boscolo-Rizzo","year":"2020","unstructured":"Boscolo-Rizzo P, Giunco S, Rampazzo E, Brutti M, Spinato G, Menegaldo A, Stellin M, Mantovani M, Bandolin L, Rossi M, Del Mistro A, Tirelli G, Dei Tos AP, Guerriero A, Niero M, Da Mosto MC, Polesel J, De Rossi A (2020) TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 146:381\u2013389","journal-title":"J Cancer Res Clin Oncol"},{"key":"369_CR45","doi-asserted-by":"publisher","first-page":"15326","DOI":"10.1038\/srep15326","volume":"5","author":"T Bourgeron","year":"2015","unstructured":"Bourgeron T, Xu Z, Doumic M, Teixeira MT (2015) The asymmetry of telomere replication contributes to replicative senescence heterogeneity. Sci Rep 5:15326","journal-title":"Sci Rep"},{"key":"369_CR46","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/genes14091693","volume":"14","author":"JP Br\u00e1s","year":"2023","unstructured":"Br\u00e1s JP, Jesus TT, Prazeres H, Lima J, Soares P, Vinagre J (2023) TERTmonitor-qPCR detection of TERTp mutations in glioma. Genes (Basel) 14:1693","journal-title":"Genes (Basel)"},{"key":"369_CR47","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/0959-8049(96)00016-0","volume":"32","author":"N Brass","year":"1996","unstructured":"Brass N, Ukena I, Remberger K, Mack U, Sybrecht G, Meese E (1996) DNA amplification on chromosome 3q26. 1-q26. 3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur J Cancer 32:1205\u20131208","journal-title":"Eur J Cancer"},{"key":"369_CR48","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O\u2019Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, Network TR (2013) The somatic genomic landscape of glioblastoma. Cell 155:462\u2013477","journal-title":"Cell"},{"key":"369_CR49","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12885-019-6177-0","volume":"19","author":"C Brito","year":"2019","unstructured":"Brito C, Azevedo A, Esteves S, Marques AR, Martins C, Costa I, Mafra M, Bravo Marques JM, Roque L, Pojo M (2019) Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC Cancer 19:968","journal-title":"BMC Cancer"},{"key":"369_CR50","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/s41379-021-00841-7","volume":"34","author":"JA Brosnan-Cashman","year":"2021","unstructured":"Brosnan-Cashman JA, Davis CM, Diplas BH, Meeker AK, Rodriguez FJ, Heaphy CM (2021) SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastoma. Mod Pathol 34:1810\u20131819","journal-title":"Mod Pathol"},{"key":"369_CR51","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/his.13318","volume":"72","author":"NA Brown","year":"2018","unstructured":"Brown NA, Lew M, Weigelin HC, Weizer AZ, Montgomery JS, Betz BL, Mehra R (2018) Comparative study of TERT promoter mutation status within spatially, temporally and morphologically distinct components of urothelial carcinoma. Histopathology 72:354\u2013356","journal-title":"Histopathology"},{"key":"369_CR52","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm1197-1271","volume":"3","author":"TM Bryan","year":"1997","unstructured":"Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR (1997a) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271\u20131274","journal-title":"Nat Med"},{"key":"369_CR53","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/hmg\/6.6.921","volume":"6","author":"TM Bryan","year":"1997","unstructured":"Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR (1997b) The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 6:921\u2013926","journal-title":"Hum Mol Genet"},{"key":"369_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.neo.7900092","volume":"2","author":"LA Bryce","year":"2000","unstructured":"Bryce LA, Morrisont N, Hoare SF, Muir S, Keith WN (2000) Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15. 33 by fluorescence in situ hybridization. Neoplasia 2:197\u2013201","journal-title":"Neoplasia"},{"key":"369_CR55","first-page":"3055","volume":"55","author":"PM Brzoska","year":"1995","unstructured":"Brzoska PM, Levin NA, Fu KK, Kaplan MJ, Singer MI, Gray JW, Christman MF (1995) Frequent novel DNA copy number increase in squamous cell head and neck tumors. Cancer Res 55:3055\u20133059","journal-title":"Cancer Res"},{"key":"369_CR56","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/ijc.31225","volume":"142","author":"R Bu","year":"2018","unstructured":"Bu R, Siraj AK, Divya SP, Kong Y, Parvathareddy SK, Al-Rasheed M, Al-Obaisi KAS, Victoria IG, Al-Sobhi SS, Al-Dawish M, Al-Dayel F, Al-Kuraya KS (2018) Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in M iddle E astern papillary thyroid cancer. Int J Cancer 142:2028\u20132039","journal-title":"Int J Cancer"},{"key":"369_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cen.12999","volume":"85","author":"M Bullock","year":"2016","unstructured":"Bullock M, Ren Y, O\u2019Neill C, Gill A, Aniss A, Sywak M, Sidhu S, Delbridge L, Learoyd D, de Vathaire F, Robinson BG, Clifton-Bligh RJ (2016) TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas. Clin Endocrinol 85:283\u2013290","journal-title":"Clin Endocrinol"},{"key":"369_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biochi.2007.07.025","volume":"90","author":"CJ Cairney","year":"2008","unstructured":"Cairney CJ, Keith WN (2008) Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. Biochimie 90:13\u201323","journal-title":"Biochimie"},{"key":"369_CR59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/ejhg.2014.195","volume":"23","author":"NC Campanella","year":"2015","unstructured":"Campanella NC, Celestino R, Pestana A, Scapulatempo-Neto C, de Oliveira AT, Brito MJ, Gouveia A, Lopes JM, Guimaraes DP, Soares P, Reis RM (2015) Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs). Eur J Hum Genet 23:877\u2013879","journal-title":"Eur J Hum Genet"},{"key":"369_CR60","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jaad.2018.08.032","volume":"80","author":"MA Campos","year":"2019","unstructured":"Campos MA, Macedo S, Fernandes M, Pestana A, Pardal J, Batista R, Vinagre J, Sanches A, Baptista A, Lopes JM, Soares P (2019) TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma. J Am Acad Dermatol 80:660\u2013669.e666","journal-title":"J Am Acad Dermatol"},{"issue":"1327\u20131341","key":"369_CR61","volume":"169","author":"Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N (2017) Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169(1327\u20131341):e1323","journal-title":"Cell"},{"key":"369_CR62","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1349-7006.2008.00815.x","volume":"99","author":"Y Cao","year":"2008","unstructured":"Cao Y, Bryan TM, Reddel RR (2008) Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 99:1092\u20131099","journal-title":"Cancer Sci"},{"key":"369_CR63","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S1470-2045(13)70110-4","volume":"14","author":"P Castelo-Branco","year":"2013","unstructured":"Castelo-Branco P, Choufani S, Mack S, Gallagher D, Zhang C, Lipman T, Zhukova N, Walker EJ, Martin D, Merino D, Wasserman JD, Elizabeth C, Alon N, Zhang L, Hovestadt V, Kool M, Jones DT, Zadeh G, Croul S, Hawkins C, Hitzler J, Wang JC, Baruchel S, Dirks PB, Malkin D, Pfister S, Taylor MD, Weksberg R, Tabori U (2013) Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol 14:534\u2013542","journal-title":"Lancet Oncol"},{"key":"369_CR64","doi-asserted-by":"publisher","first-page":"57726","DOI":"10.18632\/oncotarget.10639","volume":"7","author":"P Castelo-Branco","year":"2016","unstructured":"Castelo-Branco P, Leao R, Lipman T, Campbell B, Lee D, Price A, Zhang C, Heidari A, Stephens D, Boerno S, Coelho H, Gomes A, Domingos C, Apolonio JD, Schafer G, Bristow RG, Schweiger MR, Hamilton R, Zlotta A, Figueiredo A, Klocker H, Sultmann H, Tabori U (2016) A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study. Oncotarget 7:57726\u201357736","journal-title":"Oncotarget"},{"key":"369_CR65","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.euf.2017.09.008","volume":"5","author":"J Casuscelli","year":"2019","unstructured":"Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic A, Arcila ME, Tennenbaum DM, Ghanaat M, Kashan M, Stief CG, Carlo M, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, Hsieh JJ, Hakimi AA (2019) Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma. Eur Urol Focus 5:642\u2013649","journal-title":"Eur Urol Focus"},{"key":"369_CR66","doi-asserted-by":"publisher","first-page":"9948","DOI":"10.1128\/MCB.24.22.9948-9957.2004","volume":"24","author":"AJ Cesare","year":"2004","unstructured":"Cesare AJ, Griffith JD (2004) Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol 24:9948\u20139957","journal-title":"Mol Cell Biol"},{"key":"369_CR67","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrg2763","volume":"11","author":"AJ Cesare","year":"2010","unstructured":"Cesare AJ, Reddel RR (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11:319\u2013330","journal-title":"Nat Rev Genet"},{"key":"369_CR68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3748\/wjg.v21.i1.311","volume":"21","author":"D Cevik","year":"2015","unstructured":"Cevik D, Yildiz G, Ozturk M (2015) Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations. World J Gastroenterol 21:311\u2013317","journal-title":"World J Gastroenterol"},{"key":"369_CR69","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/hed.24728","volume":"39","author":"KP Chang","year":"2017","unstructured":"Chang KP, Wang CI, Pickering CR, Huang Y, Tsai CN, Tsang NM, Kao HK, Cheng MH, Myers JN (2017) Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma. Head Neck 39:1131\u20131137","journal-title":"Head Neck"},{"key":"369_CR70","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12072-022-10455-z","volume":"17","author":"YS Chang","year":"2023","unstructured":"Chang YS, Tu SJ, Chen HD, Hsu MH, Chen YC, Chao DS, Chung CC, Chou YP, Chang CM, Lee YT, Yen JC, Jeng LB, Chang JG (2023) Integrated genomic analyses of hepatocellular carcinoma. Hepatol Int 17:97\u2013111","journal-title":"Hepatol Int"},{"key":"369_CR71","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.1158\/0008-5472.CAN-06-0910","volume":"66","author":"YJ Chen","year":"2006","unstructured":"Chen YJ, Hakin-Smith V, Teo M, Xinarianos GE, Jellinek DA, Carroll T, McDowell D, MacFarlane MR, Boet R, Baguley BC, Braithwaite AW, Reddel RR, Royds JA (2006) Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma. Cancer Res 66:6473\u20136476","journal-title":"Cancer Res"},{"key":"369_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100297","volume":"9","author":"C Chen","year":"2014","unstructured":"Chen C, Han S, Meng L, Li Z, Zhang X, Wu A (2014) TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas. PLoS One 9:e100297","journal-title":"PLoS One"},{"key":"369_CR73","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.anndiagpath.2015.03.005","volume":"19","author":"KA Cheng","year":"2015","unstructured":"Cheng KA, Kurtis B, Babayeva S, Zhuge J, Tantchou I, Cai D, Lafaro RJ, Fallon JT, Zhong M (2015) Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites. Ann Diagn Pathol 19:146\u2013148","journal-title":"Ann Diagn Pathol"},{"key":"369_CR74","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.humpath.2017.11.011","volume":"72","author":"P Chianchiano","year":"2018","unstructured":"Chianchiano P, Pezhouh MK, Kim A, Luchini C, Cameron A, Weiss MJ, He J, Voltaggio L, Oshima K, Anders RA, Wood LD (2018) Distinction of intrahepatic metastasis from multicentric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations. Hum Pathol 72:127\u2013134","journal-title":"Hum Pathol"},{"key":"369_CR75","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1126\/science.aao0535","volume":"357","author":"K Chiba","year":"2017","unstructured":"Chiba K, Lorbeer FK, Shain AH, McSwiggen DT, Schruf E, Oh A, Ryu J, Darzacq X, Bastian BC, Hockemeyer D (2017) Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science 357:1416\u20131420","journal-title":"Science"},{"key":"369_CR76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1210\/jc.2014-1634","volume":"100","author":"AM Chindris","year":"2015","unstructured":"Chindris AM, Casler JD, Bernet VJ, Rivera M, Thomas C, Kachergus JM, Necela BM, Hay ID, Westphal SA, Grant CS, Thompson GB, Schlinkert RT, Thompson EA, Smallridge RC (2015) Clinical and molecular features of Hurthle cell carcinoma of the thyroid. J Clin Endocrinol Metab 100:55\u201362","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR77","doi-asserted-by":"publisher","first-page":"842","DOI":"10.5858\/arpa.2020-0330-OA","volume":"145","author":"WC Cho","year":"2021","unstructured":"Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP (2021) Telomerase reverse transcriptase protein expression is more frequent in Acral lentiginous melanoma than in other types of cutaneous melanoma. Arch Pathol Lab Med 145:842\u2013850","journal-title":"Arch Pathol Lab Med"},{"key":"369_CR78","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbrc.2007.07.051","volume":"361","author":"JH Choi","year":"2007","unstructured":"Choi JH, Park SH, Park J, Park BG, Cha SJ, Kong KH, Lee KH, Park AJ (2007) Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma. Biochem Biophys Res Commun 361:615\u2013620","journal-title":"Biochem Biophys Res Commun"},{"key":"369_CR79","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/jcm10102179","volume":"10","author":"YS Choi","year":"2021","unstructured":"Choi YS, Choi SW, Yi JW (2021) Prospective analysis of TERT promoter mutations in papillary thyroid carcinoma at a single institution. J Clin Med 10:2179","journal-title":"J Clin Med"},{"key":"369_CR80","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","volume":"9","author":"P Chudasama","year":"2018","unstructured":"Chudasama P, Mughal SS, Sanders MA, H\u00fcbschmann D, Chung I, Deeg KI, Wong SH, Rabe S, Hlevnjak M, Zapatka M, Ernst A, Kleinheinz K, Schlesner M, Sieverling L, Klink B, Schr\u00f6ck E, Hoogenboezem RM, Kasper B, Heilig CE, Egerer G, Wolf S, von Kalle C, Eils R, Stenzinger A, Weichert W, Glimm H, Gr\u00f6schel S, Kopp HG, Omlor G, Lehner B, Bauer S, Schimmack S, Ulrich A, Mechtersheimer G, Rippe K, Brors B, Hutter B, Renner M, Hohenberger P, Scholl C, Fr\u00f6hling S (2018) Integrative genomic and transcriptomic analysis of leiomyosarcoma. Nat Commun 9:144","journal-title":"Nat Commun"},{"key":"369_CR81","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jaad.2015.07.030","volume":"73","author":"HJ Chung","year":"2015","unstructured":"Chung HJ, Yang S, Succaria F, Bhawan J (2015) Telomerase (TERT) promoter mutations are infrequent in Merkel cell carcinomas. J Am Acad Dermatol 73:864\u2013865","journal-title":"J Am Acad Dermatol"},{"key":"369_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gde.2020.01.002","volume":"60","author":"E Claude","year":"2020","unstructured":"Claude E, Decottignies A (2020) Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof. Curr Opin Genet Dev 60:1\u20138","journal-title":"Curr Opin Genet Dev"},{"key":"369_CR83","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1126\/science.1138596","volume":"315","author":"SB Cohen","year":"2007","unstructured":"Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR (2007) Protein composition of catalytically active human telomerase from immortal cells. Science 315:1850\u20131853","journal-title":"Science"},{"key":"369_CR84","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0959-437X(99)80014-8","volume":"9","author":"LM Colgin","year":"1999","unstructured":"Colgin LM, Reddel RR (1999) Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev 9:97\u2013103","journal-title":"Curr Opin Genet Dev"},{"key":"369_CR85","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/thy.2018.0339","volume":"29","author":"C Colombo","year":"2019","unstructured":"Colombo C, Muzza M, Proverbio MC, Tosi D, Soranna D, Pesenti C, Rossi S, Cirello V, De Leo S, Fusco N, Miozzo M, Bulfamante G, Vicentini L, Ferrero S, Zambon A, Tabano S, Fugazzola L (2019) Impact of mutation density and heterogeneity on papillary thyroid cancer clinical features and remission probability. Thyroid 29:237\u2013251","journal-title":"Thyroid"},{"key":"369_CR86","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apm.13063","volume":"128","author":"S Coskun","year":"2020","unstructured":"Coskun S, Gamsizkan M, Yilmaz I, Yalcinkaya U, Sungur MA, Buyucek S, Onal B (2020) BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation? APMIS 128:515\u2013522","journal-title":"APMIS"},{"key":"369_CR87","doi-asserted-by":"publisher","first-page":"8918","DOI":"10.1158\/0008-5472.CAN-06-0273","volume":"66","author":"A Costa","year":"2006","unstructured":"Costa A, Daidone MG, Daprai L, Villa R, Cantu S, Pilotti S, Mariani L, Gronchi A, Henson JD, Reddel RR, Zaffaroni N (2006) Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res 66:8918\u20138924","journal-title":"Cancer Res"},{"key":"369_CR88","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/modpathol.2016.53","volume":"29","author":"M Cowan","year":"2016","unstructured":"Cowan M, Springer S, Nguyen D, Taheri D, Guner G, Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Cunha I, Fujita K, Ertoy D, Bivalacqua TJ, Kinzler K, Vogelstein B, Netto GJ, Papadopoulos N (2016a) High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder. Mod Pathol 29:511\u2013515","journal-title":"Mod Pathol"},{"key":"369_CR89","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2016.02.009","volume":"53","author":"ML Cowan","year":"2016","unstructured":"Cowan ML, Springer S, Nguyen D, Taheri D, Guner G, Mendoza Rodriguez MA, Wang Y, Kinde I, Del Carmen Rodriguez Pena M, VandenBussche CJ, Olson MT, Cunha I, Fujita K, Ertoy D, Kinzler K, Bivalacqua T, Papadopoulos N, Vogelstein B, Netto GJ (2016b) Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder. Hum Pathol 53:8\u201313","journal-title":"Hum Pathol"},{"key":"369_CR90","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.celrep.2016.01.011","volume":"14","author":"KE Cox","year":"2016","unstructured":"Cox KE, Mar\u00e9chal A, Flynn RL (2016) SMARCAL1 resolves replication stress at ALT telomeres. Cell Rep 14:1032\u20131040","journal-title":"Cell Rep"},{"key":"369_CR91","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/PAS.0000000000001489","volume":"44","author":"V Cracolici","year":"2020","unstructured":"Cracolici V, Ritterhouse LL, Segal JP, Puranik R, Wanjari P, Kadri S, Parilla M, Cipriani NA (2020) Follicular thyroid neoplasms: comparison of clinicopathologic and molecular features of atypical adenomas and follicular thyroid carcinomas. Am J Surg Pathol 44:881\u2013892","journal-title":"Am J Surg Pathol"},{"key":"369_CR92","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1590\/1678-4685-gmb-2017-0133","volume":"41","author":"A Cruvinel-Carloni","year":"2018","unstructured":"Cruvinel-Carloni A, Yamane L, Scapulatempo-Neto C, Guimar\u00e3es D, Reis RM (2018) Absence of TERT promoter mutations in colorectal precursor lesions and cancer. Genet Mol Biol 41:82\u201384","journal-title":"Genet Mol Biol"},{"key":"369_CR93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fgene.2015.00143","volume":"6","author":"E Cusanelli","year":"2015","unstructured":"Cusanelli E, Chartrand P (2015) Telomeric repeat-containing RNA TERRA: a noncoding RNA connecting telomere biology to genome integrity. Front Genet 6:143","journal-title":"Front Genet"},{"key":"369_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.643151","volume":"12","author":"VR da Costa","year":"2021","unstructured":"da Costa VR, Bim LV, Pacheco ESLDP, Colloza-Gama GA, Bastos AU, Delcelo R, Oler G, Cerutti JM (2021) Advances in detecting low prevalence somatic TERT promoter mutations in papillary thyroid carcinoma. Front Endocrinol (Lausanne) 12:643151","journal-title":"Front Endocrinol (Lausanne)"},{"key":"369_CR95","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/jnen\/nlaa074","volume":"79","author":"P Dal Col","year":"2020","unstructured":"Dal Col P, Poncet D, Rivoirard R, Vassal F, Bernichon E, Boutet C, P\u00e9oc\u2019h M, Forest F (2020) Acquired ATRX loss and ALT phenotype through tumor recurrences in a case of pleomorphic xanthoastrocytoma suggest their possible roles in tumor progression. J Neuropathol Exp Neurol 79:1011\u20131014","journal-title":"J Neuropathol Exp Neurol"},{"key":"369_CR96","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1089\/thy.2015.0101","volume":"25","author":"D de Biase","year":"2015","unstructured":"de Biase D, Gandolfi G, Ragazzi M, Eszlinger M, Sancisi V, Gugnoni M, Visani M, Pession A, Casadei G, Durante C, Costante G, Bruno R, Torlontano M, Paschke R, Filetti S, Piana S, Frasoldati A, Tallini G, Ciarrocchi A (2015) TERT promoter mutations in papillary thyroid microcarcinomas. Thyroid 25:1013\u20131019","journal-title":"Thyroid"},{"key":"369_CR97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejca.2017.12.027","volume":"92","author":"C de la Fouchardi\u00e8re","year":"2018","unstructured":"de la Fouchardi\u00e8re C, Decaussin-Petrucci M, Berthiller J, Descotes F, Lopez J, Lifante JC, Peix JL, Giraudet AL, Delahaye A, Masson S, Bournaud-Salinas C, Borson Chazot F (2018) Predictive factors of outcome in poorly differentiated thyroid carcinomas. Eur J Cancer 92:40\u201347","journal-title":"Eur J Cancer"},{"key":"369_CR98","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1126\/science.1170633","volume":"326","author":"T de Lange","year":"2009","unstructured":"de Lange T (2009) How telomeres solve the end-protection problem. Science 326:948\u2013952","journal-title":"Science"},{"key":"369_CR99","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.molcel.2009.06.025","volume":"35","author":"Z Deng","year":"2009","unstructured":"Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM (2009) TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell 35:403\u2013413","journal-title":"Mol Cell"},{"key":"369_CR100","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/bjc.2017.210","volume":"117","author":"F Descotes","year":"2017","unstructured":"Descotes F, Kara N, Decaussin-Petrucci M, Piaton E, Geiguer F, Rodriguez-Lafrasse C, Terrier JE, Lopez J, Ruffion A (2017) Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine. Br J Cancer 117:583\u2013587","journal-title":"Br J Cancer"},{"key":"369_CR101","first-page":"537","volume":"60","author":"SK Dessain","year":"2000","unstructured":"Dessain SK, Yu HY, Reddel RR, Beijersbergen RL, Weinberg RA (2000) Methylation of the human telomerase gene CpG Island. Cancer Res 60:537\u2013541","journal-title":"Cancer Res"},{"key":"369_CR102","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/ERC-15-0057","volume":"22","author":"MS Dettmer","year":"2015","unstructured":"Dettmer MS, Schmitt A, Steinert H, Capper D, Moch H, Komminoth P, Perren A (2015) Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocr Relat Cancer 22:419\u2013429","journal-title":"Endocr Relat Cancer"},{"key":"369_CR103","doi-asserted-by":"publisher","first-page":"R315","DOI":"10.1530\/ERC-17-0012","volume":"24","author":"A Di Domenico","year":"2017","unstructured":"Di Domenico A, Wiedmer T, Marinoni I, Perren A (2017) Genetic and epigenetic drivers of neuroendocrine tumours (NET). Endocr Relat Cancer 24:R315\u2013R334","journal-title":"Endocr Relat Cancer"},{"key":"369_CR104","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/bjd.15836","volume":"177","author":"D Dias-Santagata","year":"2017","unstructured":"Dias-Santagata D, Selim MA, Su Y, Peng Y, Vollmer R, Chlopik A, Tell-Marti G, Paral KM, Shalin SC, Shea CR, Puig S, Fernandez-Figueras MT, Biernat W, Rys J, Marszalek A, Hoang MP (2017) KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas. Br J Dermatol 177:1376\u20131384","journal-title":"Br J Dermatol"},{"key":"369_CR105","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jaad.2014.05.035","volume":"71","author":"A Diaz","year":"2014","unstructured":"Diaz A, Puig-Butille JA, Munoz C, Costa D, Diez A, Garcia-Herrera A, Carrera C, Badenas C, Sole F, Malvehy J, Puig S, Alos L (2014) TERT gene amplification is associated with poor outcome in acral lentiginous melanoma. J Am Acad Dermatol 71:839\u2013841","journal-title":"J Am Acad Dermatol"},{"key":"369_CR106","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/sj.leu.2400635","volume":"11","author":"J Dierlamm","year":"1997","unstructured":"Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodarska I, Michaux L, Dehaen M, Verhoef G, Thomas J, De Kelver W (1997) Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 11:747","journal-title":"Leukemia"},{"key":"369_CR107","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.trecan.2015.07.007","volume":"1","author":"RL Dilley","year":"2015","unstructured":"Dilley RL, Greenberg RA (2015) ALTernative telomere maintenance and cancer. Trends Cancer 1:145\u2013156","journal-title":"Trends Cancer"},{"key":"369_CR108","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature20099","volume":"539","author":"RL Dilley","year":"2016","unstructured":"Dilley RL, Verma P, Cho NW, Winters HD, Wondisford AR, Greenberg RA (2016) Break-induced telomere synthesis underlies alternative telomere maintenance. Nature 539:54\u201358","journal-title":"Nature"},{"key":"369_CR109","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41467-018-04448-6","volume":"9","author":"BH Diplas","year":"2018","unstructured":"Diplas BH, He X, Brosnan-Cashman JA, Liu H, Chen LH, Wang Z, Moure CJ, Killela PJ, Loriaux DB, Lipp ES, Greer PK, Yang R, Rizzo AJ, Rodriguez FJ, Friedman AH, Friedman HS, Wang S, He Y, McLendon RE, Bigner DD, Jiao Y, Waitkus MS, Meeker AK, Yan H (2018) The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma. Nat Commun 9:2087","journal-title":"Nat Commun"},{"key":"369_CR110","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jamcollsurg.2014.01.001","volume":"218","author":"E Dogeas","year":"2014","unstructured":"Dogeas E, Karagkounis G, Heaphy CM, Hirose K, Pawlik TM, Wolfgang CL, Meeker A, Hruban RH, Cameron JL, Choti MA (2014) Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases. J Am Coll Surg 218:628\u2013635","journal-title":"J Am Coll Surg"},{"key":"369_CR111","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/bjc.2013.804","volume":"110","author":"M Dono","year":"2014","unstructured":"Dono M, Angelini G, Cecconi M, Amaro A, Esposito AI, Mirisola V, Maric I, Lanza F, Nasciuti F, Viaggi S, Gualco M, Bandelloni R, Truini M, Coviello DA, Zupo S, Mosci C, Pfeffer U (2014) Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma. Br J Cancer 110:1058\u20131065","journal-title":"Br J Cancer"},{"key":"369_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPH.0000000000000840","volume":"40","author":"XF Duan","year":"2017","unstructured":"Duan XF, Zhao Q (2017) TERT-mediated and ATRX-mediated telomere maintenance and neuroblastoma. J Pediatr Hematol Oncol 40:1\u20136","journal-title":"J Pediatr Hematol Oncol"},{"key":"369_CR113","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11060-014-1553-8","volume":"120","author":"HJ Dubbink","year":"2014","unstructured":"Dubbink HJ, Bakels H, Post E, Zwarthoff EC, Verdijk RM (2014) TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors. J Neuro-Oncol 120:267\u2013272","journal-title":"J Neuro-Oncol"},{"key":"369_CR114","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/82586","volume":"26","author":"MA Dunham","year":"2000","unstructured":"Dunham MA, Neumann AA, Fasching CL, Reddel RR (2000) Telomere maintenance by recombination in human cells. Nat Genet 26:447\u2013450","journal-title":"Nat Genet"},{"key":"369_CR115","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O\u2019Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499\u20132508","journal-title":"N Engl J Med"},{"key":"369_CR116","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/CMR.0000000000000048","volume":"24","author":"F Egberts","year":"2014","unstructured":"Egberts F, Kruger S, Behrens HM, Bergner I, Papaspyrou G, Werner JA, Alkatout I, Haag J, Hauschild A, Rocken C (2014) Melanomas of unknown primary frequently harbor TERT-promoter mutations. Melanoma Res 24:131\u2013136","journal-title":"Melanoma Res"},{"key":"369_CR117","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jmoldx.2015.07.010","volume":"18","author":"F Egberts","year":"2016","unstructured":"Egberts F, Bohne AS, Kruger S, Hedderich J, Rompel R, Haag J, Rocken C, Hauschild A (2016) Varying mutational alterations in multiple primary melanomas. J Mol Diagn 18:75\u201383","journal-title":"J Mol Diagn"},{"key":"369_CR118","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenm\u00fcller","year":"2014","unstructured":"Eichenm\u00fcller M, Trippel F, Kreuder M, Beck A, Schwarzmayr T, H\u00e4berle B, Cairo S, Leuschner I, von Schweinitz D, Strom TM (2014) The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 61:1312\u20131320","journal-title":"J Hepatol"},{"key":"369_CR119","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/pcmr.12500","volume":"29","author":"H Ekedahl","year":"2016","unstructured":"Ekedahl H, Lauss M, Olsson H, Griewank KG, Schadendorf D, Ingvar C, Jonsson G (2016) High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma. Pigment Cell Melanoma Res 29:598\u2013600","journal-title":"Pigment Cell Melanoma Res"},{"key":"369_CR120","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.3390\/ijms22083826","volume":"22","author":"L Elefanti","year":"2021","unstructured":"Elefanti L, Zamuner C, Del Fiore P, Stagni C, Pellegrini S, Dall\u2019Olmo L, Fabozzi A, Senetta R, Ribero S, Salmaso R, Mocellin S, Bassetto F, Cavallin F, Tosi AL, Galuppini F, Dei Tos AP, Menin C, Cappellesso R (2021) The molecular landscape of primary Acral melanoma: a multicenter study of the Italian melanoma intergroup (IMI). Int J Mol Sci 22:3826","journal-title":"Int J Mol Sci"},{"key":"369_CR121","first-page":"3230","volume":"56","author":"W el-Rifai","year":"1996","unstructured":"el-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuutila S, Andersson LC (1996) DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. Cancer Res 56:3230\u20133233","journal-title":"Cancer Res"},{"key":"369_CR122","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1210\/jc.2007-1840","volume":"93","author":"T Else","year":"2008","unstructured":"Else T, Giordano TJ, Hammer GD (2008) Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. J Clin Endocrinol Metab 93:1442\u20131449","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR123","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1093\/nar\/gku114","volume":"42","author":"H Episkopou","year":"2014","unstructured":"Episkopou H, Draskovic I, Van Beneden A, Tilman G, Mattiussi M, Gobin M, Arnoult N, Londono-Vallejo A, Decottignies A (2014) Alternative lengthening of telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Res 42:4391\u20134405","journal-title":"Nucleic Acids Res"},{"key":"369_CR124","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.celrep.2016.12.005","volume":"18","author":"F Erdel","year":"2017","unstructured":"Erdel F, Kratz K, Willcox S, Griffith JD, Greene EC, de Lange T (2017) Telomere recognition and assembly mechanism of mammalian Shelterin. Cell Rep 18:41\u201353","journal-title":"Cell Rep"},{"key":"369_CR125","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2217\/fon-2017-0167","volume":"13","author":"I Faleiro","year":"2017","unstructured":"Faleiro I, Apolonio JD, Price AJ, De Mello RA, Roberto VP, Tabori U, Castelo-Branco P (2017) The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer. Future Oncol 13:2045\u20132051","journal-title":"Future Oncol"},{"key":"369_CR126","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0002-9440(10)64311-8","volume":"162","author":"X Fan","year":"2003","unstructured":"Fan X, Wang Y, Kratz J, Brat DJ, Robitaille Y, Moghrabi A, Perlman EJ, Dang CV, Burger PC, Eberhart CG (2003) hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. Am J Pathol 162:1763\u20131769","journal-title":"Am J Pathol"},{"key":"369_CR127","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11060-016-2132-y","volume":"128","author":"X Fan","year":"2016","unstructured":"Fan X, Wang Y, Liu Y, Liu X, Zhang C, Wang L, Li S, Ma J, Jiang T (2016a) Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas. J Neuro-Oncol 128:455\u2013462","journal-title":"J Neuro-Oncol"},{"key":"369_CR128","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/JID.2015.374","volume":"136","author":"Y Fan","year":"2016","unstructured":"Fan Y, Lee S, Wu G, Easton J, Yergeau D, Dummer R, Vogel P, Kirkwood JM, Barnhill RL, Pappo A, Bahrami A (2016b) Telomerase expression by aberrant methylation of the TERT promoter in melanoma arising in Giant congenital nevi. J Invest Dermatol 136:339\u2013342","journal-title":"J Invest Dermatol"},{"key":"369_CR129","first-page":"1074","volume":"20","author":"W Feng","year":"2015","unstructured":"Feng W, Han Z, Zhu R, Liu P, Liu S (2015) Association of p16 gene methylation with prostate cancer risk: a meta-analysis. J BUON 20:1074\u20131080","journal-title":"J BUON"},{"key":"369_CR130","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/ijms19020608","volume":"19","author":"MSV Ferreira","year":"2018","unstructured":"Ferreira MSV, Crysandt M, Braunschweig T, Jost E, Voss B, Bouillon AS, Knuechel R, Br\u00fcmmendorf TH, Beier F (2018) Presence of TERT promoter mutations is a secondary event and associates with elongated telomere length in Myxoid Liposarcomas. Int J Mol Sci 19:608","journal-title":"Int J Mol Sci"},{"key":"369_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-020-03394-y","volume":"147","author":"MSV Ferreira","year":"2020","unstructured":"Ferreira MSV, S\u00f8rensen MD, Pusch S, Beier D, Bouillon AS, Kristensen BW, Br\u00fcmmendorf TH, Beier CP, Beier F (2020) Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation. J Neuro-Oncol 147:1\u201314","journal-title":"J Neuro-Oncol"},{"key":"369_CR132","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/COC.0000000000000012","volume":"38","author":"A Flacco","year":"2015","unstructured":"Flacco A, Ludovini V, Bianconi F, Ragusa M, Bellezza G, Tofanetti FR, Pistola L, Siggillino A, Vannucci J, Cagini L, Sidoni A, Puma F, Varella-Garcia M, Crino L (2015) MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer. Am J Clin Oncol 38:152\u2013158","journal-title":"Am J Clin Oncol"},{"key":"369_CR133","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1126\/science.1257216","volume":"347","author":"RL Flynn","year":"2015","unstructured":"Flynn RL, Cox KE, Jeitany M, Wakimoto H, Bryll AR, Ganem NJ, Bersani F, Pineda JR, Suva ML, Benes CH, Haber DA, Boussin FD, Zou L (2015) Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science 347:273\u2013277","journal-title":"Science"},{"key":"369_CR134","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11060-017-2585-7","volume":"135","author":"A Fogli","year":"2017","unstructured":"Fogli A, Demattei MV, Corset L, Vaurs-Barriere C, Chautard E, Biau J, Kemeny JL, Godfraind C, Pereira B, Khalil T, Grandin N, Arnaud P, Charbonneau M, Verrelle P (2017) Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis. J Neuro-Oncol 135:381\u2013390","journal-title":"J Neuro-Oncol"},{"key":"369_CR135","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1600-0714.2007.00531.x","volume":"36","author":"K Freier","year":"2007","unstructured":"Freier K, Pungs S, Flechtenmacher C, Bosch FX, Lichter P, Joos S, Hofele C (2007) Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma. J Oral Pathol Med 36:267\u2013272","journal-title":"J Oral Pathol Med"},{"key":"369_CR136","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/ncomms7120","volume":"6","author":"A Fujimoto","year":"2015","unstructured":"Fujimoto A, Furuta M, Shiraishi Y, Gotoh K, Kawakami Y, Arihiro K, Nakamura T, Ueno M, Ariizumi S, Nguyen HH, Shigemizu D, Abe T, Boroevich KA, Nakano K, Sasaki A, Kitada R, Maejima K, Yamamoto Y, Tanaka H, Shibuya T, Shibata T, Ojima H, Shimada K, Hayami S, Shigekawa Y, Aikata H, Ohdan H, Marubashi S, Yamada T, Kubo M, Hirano S, Ishikawa O, Yamamoto M, Yamaue H, Chayama K, Miyano S, Tsunoda T, Nakagawa H (2015) Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nat Commun 6:6120","journal-title":"Nat Commun"},{"key":"369_CR137","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/EJE-14-0837","volume":"172","author":"G Gandolfi","year":"2015","unstructured":"Gandolfi G, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A, Sancisi V (2015) TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma. Eur J Endocrinol 172:403\u2013413","journal-title":"Eur J Endocrinol"},{"key":"369_CR138","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","volume":"34","author":"I Ganly","year":"2018","unstructured":"Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, Nanjangud G, Eng S, Bose P, Kuo F, Morris LGT, Landa I, Carrillo Albornoz PB, Riaz N, Nikiforov YE, Patel K, Umbricht C, Zeiger M, Kebebew E, Sherman E, Ghossein R, Fagin JA, Chan TA (2018) Integrated genomic analysis of H\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes. Cancer Cell 34:256\u2013270.e255","journal-title":"Cancer Cell"},{"key":"369_CR139","doi-asserted-by":"publisher","first-page":"8712","DOI":"10.18632\/oncotarget.6007","volume":"7","author":"K Gao","year":"2016","unstructured":"Gao K, Li G, Qu Y, Wang M, Cui B, Ji M, Shi B, Hou P (2016) TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas. Oncotarget 7:8712\u20138725","journal-title":"Oncotarget"},{"key":"369_CR140","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ng1278","volume":"36","author":"M Garcia-Cao","year":"2004","unstructured":"Garcia-Cao M, O\u2019Sullivan R, Peters AH, Jenuwein T, Blasco MA (2004) Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36:94\u201399","journal-title":"Nat Genet"},{"key":"369_CR141","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/bjc.2017.450","volume":"118","author":"DA Garcia-Dios","year":"2018","unstructured":"Garcia-Dios DA, Levi D, Shah V, Gillett C, Simpson MA, Hanby A, Tomlinson I, Sawyer EJ (2018) MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours. Br J Cancer 118:277\u2013284","journal-title":"Br J Cancer"},{"key":"369_CR142","doi-asserted-by":"publisher","first-page":"77540","DOI":"10.18632\/oncotarget.20560","volume":"8","author":"M Gay-Bellile","year":"2017","unstructured":"Gay-Bellile M, V\u00e9ron\u00e8se L, Combes P, Eymard-Pierre E, Kwiatkowski F, Dauplat M-M, Cayre A, Privat M, Abrial C, Bignon Y-J (2017) TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer. Oncotarget 8:77540","journal-title":"Oncotarget"},{"key":"369_CR143","first-page":"230","volume":"13","author":"J Ge","year":"2020","unstructured":"Ge J, Liu MY, Li L, Deng Q, Liu F, Luo Y, Wang L, Yao G, Zhu D, Lu H, Liang M, Deng S, Zhou R, Luo T (2020) Detection of IDH1 and TERT promoter mutations with droplet digital PCR in diffuse gliomas. Int J Clin Exp Pathol 13:230\u2013238","journal-title":"Int J Clin Exp Pathol"},{"key":"369_CR144","doi-asserted-by":"publisher","first-page":"E1550","DOI":"10.1210\/jc.2015-2690","volume":"100","author":"JR George","year":"2015","unstructured":"George JR, Henderson YC, Williams MD, Roberts DB, Hei H, Lai SY, Clayman GL (2015) Association of TERT promoter mutation, but not BRAF mutation, with increased mortality in PTC. J Clin Endocrinol Metab 100:E1550\u2013E1559","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR145","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11060-020-03675-6","volume":"151","author":"I Gomes","year":"2021","unstructured":"Gomes I, Moreno DA, Dos Reis MB, da Silva LS, Leal LF, Gon\u00e7alves GM, Pereira CA, Oliveira MA, de Medeiros MM, Reis RM (2021) Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide. J Neuro-Oncol 151:135\u2013144","journal-title":"J Neuro-Oncol"},{"key":"369_CR146","doi-asserted-by":"publisher","first-page":"752","DOI":"10.4161\/cc.4.6.1720","volume":"4","author":"S Gonzalo","year":"2005","unstructured":"Gonzalo S, Blasco MA (2005) Role of Rb family in the epigenetic definition of chromatin. Cell Cycle 4:752\u2013755","journal-title":"Cell Cycle"},{"key":"369_CR147","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/ncb1235","volume":"7","author":"S Gonzalo","year":"2005","unstructured":"Gonzalo S, Garcia-Cao M, Fraga MF, Schotta G, Peters AHFM, Cotter SE, Eguia R, Dean DC, Esteller M, Jenuwein T, Blasco MA (2005) Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 7:420\u2013U452","journal-title":"Nat Cell Biol"},{"key":"369_CR148","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ncb1386","volume":"8","author":"S Gonzalo","year":"2006","unstructured":"Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA (2006) DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8:416\u2013424","journal-title":"Nat Cell Biol"},{"key":"369_CR149","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bpa.12110","volume":"24","author":"S Goutagny","year":"2014","unstructured":"Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24:184\u2013189","journal-title":"Brain Pathol"},{"key":"369_CR150","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/gut.2009.200022","volume":"59","author":"WM Grady","year":"2010","unstructured":"Grady WM, Tewari M (2010) The next thing in prognostic molecular markers: microRNA signatures of cancer. Gut 59:706\u2013708","journal-title":"Gut"},{"key":"369_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080354","volume":"8","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Murali R, Schilling B, Schimming T, Moller I, Moll I, Schwamborn M, Sucker A, Zimmer L, Schadendorf D, Hillen U (2013a) TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. PLoS One 8:e80354","journal-title":"PLoS One"},{"key":"369_CR152","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/bjc.2013.312","volume":"109","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Murali R, Schilling B, Scholz S, Sucker A, Song M, Susskind D, Grabellus F, Zimmer L, Hillen U, Steuhl KP, Schadendorf D, Westekemper H, Zeschnigk M (2013b) TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer 109:497\u2013501","journal-title":"Br J Cancer"},{"key":"369_CR153","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju246","volume":"106","author":"KG Griewank","year":"2014","unstructured":"Griewank KG, Murali R, Puig-Butille JA, Schilling B, Livingstone E, Potrony M, Carrera C, Schimming T, Moller I, Schwamborn M, Sucker A, Hillen U, Badenas C, Malvehy J, Zimmer L, Scherag A, Puig S, Schadendorf D (2014a) TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma. J Natl Cancer Inst 106:dju246","journal-title":"J Natl Cancer Inst"},{"key":"369_CR154","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/modpathol.2013.168","volume":"27","author":"KG Griewank","year":"2014","unstructured":"Griewank KG, Schilling B, Murali R, Bielefeld N, Schwamborn M, Sucker A, Zimmer L, Hillen U, Schaller J, Brenn T, Schadendorf D, Mentzel T (2014b) TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas. Mod Pathol 27:502\u2013508","journal-title":"Mod Pathol"},{"key":"369_CR155","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cncr.33918","volume":"128","author":"S Gritsch","year":"2022","unstructured":"Gritsch S, Batchelor TT, Gonzalez Castro LN (2022) Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. Cancer 128:47\u201358","journal-title":"Cancer"},{"key":"369_CR156","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0014-4827(03)00281-7","volume":"289","author":"I Guilleret","year":"2003","unstructured":"Guilleret I, Benhattar J (2003) Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 289:326\u2013334","journal-title":"Exp Cell Res"},{"key":"369_CR157","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ijc.10593","volume":"101","author":"I Guilleret","year":"2002","unstructured":"Guilleret I, Yan P, Grange F, Braunschweig R, Bosman FT, Benhattar J (2002) Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer 101:335\u2013341","journal-title":"Int J Cancer"},{"key":"369_CR158","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12022-021-09691-0","volume":"33","author":"S Gupta","year":"2022","unstructured":"Gupta S, Won H, Chadalavada K, Nanjangud GJ, Chen YB, Al-Ahmadie HA, Fine SW, Sirintrapun SJ, Strong VE, Raj N, Lagunes DR, Vanderbilt CM, Berger MF, Ladanyi M, Dogan S, Tickoo SK, Reuter VE, Gopalan A (2022) TERT copy number alterations, promoter mutations and rearrangements in adrenocortical carcinomas. Endocr Pathol 33:304\u2013314","journal-title":"Endocr Pathol"},{"key":"369_CR159","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/gutjnl-2020-322595","volume":"71","author":"WM Hackeng","year":"2022","unstructured":"Hackeng WM, Brosens LAA, Kim JY, O\u2019Sullivan R, Sung YN, Liu TC, Cao D, Heayn M, Brosnan-Cashman J, An S, Morsink FHM, Heidsma CM, Valk GD, Vriens MR, Nieveen van Dijkum E, Offerhaus GJA, Dreijerink KMA, Zeh H, Zureikat AH, Hogg M, Lee K, Geller D, Marsh JW, Paniccia A, Ongchin M, Pingpank JF, Bahary N, Aijazi M, Brand R, Chennat J, Das R, Fasanella KE, Khalid A, McGrath K, Sarkaria S, Singh H, Slivka A, Nalesnik M, Han X, Nikiforova MN, Lawlor RT, Mafficini A, Rusev B, Corbo V, Luchini C, Bersani S, Pea A, Cingarlini S, Landoni L, Salvia R, Milione M, Milella M, Scarpa A, Hong SM, Heaphy CM, Singhi AD (2022) Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size. Gut 71:961\u2013973","journal-title":"Gut"},{"key":"369_CR160","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0140-6736(03)12681-5","volume":"361","author":"V Hakin-Smith","year":"2003","unstructured":"Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR, Royds JA (2003) Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361:836\u2013838","journal-title":"Lancet"},{"key":"369_CR161","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"369_CR162","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch AM, Kakavand H, Alexandrov LB, Burke H, Jakrot V, Kazakoff S, Holmes O, Leonard C, Sabarinathan R, Mularoni L, Wood S, Xu Q, Waddell N, Tembe V, Pupo GM, De Paoli-Iseppi R, Vilain RE, Shang P, Lau LMS, Dagg RA, Schramm SJ, Pritchard A, Dutton-Regester K, Newell F, Fitzgerald A, Shang CA, Grimmond SM, Pickett HA, Yang JY, Stretch JR, Behren A, Kefford RF, Hersey P, Long GV, Cebon J, Shackleton M, Spillane AJ, Saw RPM, Lopez-Bigas N, Pearson JV, Thompson JF, Scolyer RA, Mann GJ (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545:175\u2013180","journal-title":"Nature"},{"key":"369_CR163","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.humpath.2022.07.015","volume":"129","author":"CM Heaphy","year":"2022","unstructured":"Heaphy CM, Singhi AD (2022) The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumors. Hum Pathol 129:11\u201320","journal-title":"Hum Pathol"},{"key":"369_CR164","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1126\/science.1207313","volume":"333","author":"CM Heaphy","year":"2011","unstructured":"Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, Offerhaus GJ, McLendon R, Rasheed BA, He Y, Yan H, Bigner DD, Oba-Shinjo SM, Marie SK, Riggins GJ, Kinzler KW, Vogelstein B, Hruban RH, Maitra A, Papadopoulos N, Meeker AK (2011a) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333:425","journal-title":"Science"},{"key":"369_CR165","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ajpath.2011.06.018","volume":"179","author":"CM Heaphy","year":"2011","unstructured":"Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih Ie M, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AK (2011b) Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179:1608\u20131615","journal-title":"Am J Pathol"},{"key":"369_CR166","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrrev.2016.11.002","volume":"771","author":"B Heidenreich","year":"2017","unstructured":"Heidenreich B, Kumar R (2017) TERT promoter mutations in telomere biology. Mutat Res 771:15\u201331","journal-title":"Mutat Res"},{"key":"369_CR167","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1038\/ncomms4401","volume":"5","author":"B Heidenreich","year":"2014","unstructured":"Heidenreich B, Nagore E, Rachakonda PS, Garcia-Casado Z, Requena C, Traves V, Becker J, Soufir N, Hemminki K, Kumar R (2014a) Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat Commun 5:3401","journal-title":"Nat Commun"},{"key":"369_CR168","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gde.2013.11.005","volume":"24","author":"B Heidenreich","year":"2014","unstructured":"Heidenreich B, Rachakonda PS, Hemminki K, Kumar R (2014b) TERT promoter mutations in cancer development. Curr Opin Genet Dev 24:30\u201337","journal-title":"Curr Opin Genet Dev"},{"key":"369_CR169","doi-asserted-by":"publisher","first-page":"10617","DOI":"10.18632\/oncotarget.3329","volume":"6","author":"B Heidenreich","year":"2015","unstructured":"Heidenreich B, Rachakonda PS, Hosen I, Volz F, Hemminki K, Weyerbrock A, Kumar R (2015) TERT promoter mutations and telomere length in adult malignant gliomas and recurrences. Oncotarget 6:10617\u201310633","journal-title":"Oncotarget"},{"key":"369_CR170","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1016\/j.febslet.2010.06.009","volume":"584","author":"JD Henson","year":"2010","unstructured":"Henson JD, Reddel RR (2010) Assaying and investigating alternative lengthening of telomeres activity in human cells and cancers. FEBS Lett 584:3800\u20133811","journal-title":"FEBS Lett"},{"key":"369_CR171","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1158\/1078-0432.217.11.1","volume":"11","author":"JD Henson","year":"2005","unstructured":"Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo JY, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu DH, Pollock RE, Reddel RR (2005) A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11:217\u2013225","journal-title":"Clin Cancer Res"},{"key":"369_CR172","doi-asserted-by":"publisher","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","volume":"95","author":"JG Herman","year":"1998","unstructured":"Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95:6870\u20136875","journal-title":"Proc Natl Acad Sci USA"},{"key":"369_CR173","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/15384101.2015.1125243","volume":"15","author":"F Hertwig","year":"2016","unstructured":"Hertwig F, Peifer M, Fischer M (2016) Telomere maintenance is pivotal for high-risk neuroblastoma. Cell Cycle 15:311\u2013312","journal-title":"Cell Cycle"},{"key":"369_CR174","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1073\/pnas.93.1.479","volume":"93","author":"K Heselmeyer","year":"1996","unstructured":"Heselmeyer K, Schr\u00f6ck E, Du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479\u2013484","journal-title":"Proc Natl Acad Sci USA"},{"key":"369_CR175","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y","volume":"19","author":"K Heselmeyer-Haddad","year":"1997","unstructured":"Heselmeyer-Haddad K, Macville M, Schr\u00f6ck E, Blegen H, Hellstr\u00f6m A-C, Shah K, Auer G, Ried T (1997) Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 19:233\u2013240","journal-title":"Genes Chromosomes Cancer"},{"key":"369_CR176","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9440(10)63498-0","volume":"163","author":"K Heselmeyer-Haddad","year":"2003","unstructured":"Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T (2003) Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol 163:1405\u20131416","journal-title":"Am J Pathol"},{"key":"369_CR177","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","volume":"166","author":"K Heselmeyer-Haddad","year":"2005","unstructured":"Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T (2005) Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol 166:1229\u20131238","journal-title":"Am J Pathol"},{"key":"369_CR178","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/pin.12900","volume":"70","author":"T Hirokawa","year":"2020","unstructured":"Hirokawa T, Arimasu Y, Chiba T, Fujiwara M, Kamma H (2020a) Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma. Pathol Int 70:217\u2013223","journal-title":"Pathol Int"},{"key":"369_CR179","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/pin.12893","volume":"70","author":"T Hirokawa","year":"2020","unstructured":"Hirokawa T, Arimasu Y, Nakazato Y, Chiba T, Fujiwara M, Kamma H (2020b) Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development. Pathol Int 70:210\u2013216","journal-title":"Pathol Int"},{"key":"369_CR180","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339:959\u2013961","journal-title":"Science"},{"key":"369_CR181","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/ijc.29526","volume":"137","author":"I Hosen","year":"2015","unstructured":"Hosen I, Rachakonda PS, Heidenreich B, de Verdier PJ, Ryk C, Steineck G, Hemminki K, Kumar R (2015a) Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer. Int J Cancer 137:1621\u20131629","journal-title":"Int J Cancer"},{"key":"369_CR182","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1002\/ijc.29279","volume":"136","author":"I Hosen","year":"2015","unstructured":"Hosen I, Rachakonda PS, Heidenreich B, Sitaram RT, Ljungberg B, Roos G, Hemminki K, Kumar R (2015b) TERT promoter mutations in clear cell renal cell carcinoma. Int J Cancer 136:2448\u20132452","journal-title":"Int J Cancer"},{"key":"369_CR183","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339:957\u2013959","journal-title":"Science"},{"key":"369_CR184","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ejca.2015.03.010","volume":"51","author":"DS Huang","year":"2015","unstructured":"Huang DS, Wang Z, He XJ, Diplas BH, Yang R, Killela PJ, Meng Q, Ye ZY, Wang W, Jiang XT, Xu L, He XL, Zhao ZS, Xu WJ, Wang HJ, Ma YY, Xia YJ, Li L, Zhang RX, Jin T, Zhao ZK, Xu J, Yu S, Wu F, Liang J, Wang S, Jiao Y, Yan H, Tao HQ (2015a) Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation. Eur J Cancer 51:969\u2013976","journal-title":"Eur J Cancer"},{"key":"369_CR185","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/modpathol.2014.93","volume":"28","author":"HN Huang","year":"2015","unstructured":"Huang HN, Chiang YC, Cheng WF, Chen CA, Lin MC, Kuo KT (2015b) Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation. Mod Pathol 28:303\u2013311","journal-title":"Mod Pathol"},{"key":"369_CR186","doi-asserted-by":"publisher","first-page":"26288","DOI":"10.18632\/oncotarget.15458","volume":"8","author":"W Huang","year":"2017","unstructured":"Huang W, Zhou W, Li C, Yang Y, Shang YK, Chen C, Zhang J, Yao R, Wang P, Wen W, Liu HQ, Wang L, Li X, Bian H, Chen ZN (2017) Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma. Oncotarget 8:26288\u201326297","journal-title":"Oncotarget"},{"key":"369_CR187","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.eururo.2013.08.057","volume":"65","author":"CD Hurst","year":"2014","unstructured":"Hurst CD, Platt FM, Knowles MA (2014) Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. Eur Urol 65:367\u2013369","journal-title":"Eur Urol"},{"key":"369_CR188","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/ijc.23672","volume":"123","author":"KT Hwang","year":"2008","unstructured":"Hwang KT, Han W, Cho J, Lee JW, Ko E, Kim EK, Jung SY, Jeong EM, Bae JY, Kang JJ, Yang SJ, Kim SW, Noh DY (2008) Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer 123:1807\u20131815","journal-title":"Int J Cancer"},{"key":"369_CR189","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.euf.2017.07.004","volume":"5","author":"S Isharwal","year":"2019","unstructured":"Isharwal S, Audenet F, Drill E, Pietzak EJ, Iyer G, Ostrovnaya I, Cha E, Donahue T, Arcila M, Jayakumaran G, Berger MF, Rosenberg JE, Bajorin DF, Coleman J, Dalbagni G, Reuter VE, Bochner BH, Solit DB, Al-Ahmadie HA (2019) Prognostic value of TERT alterations, mutational and copy number alterations burden in urothelial carcinoma. Eur Urol Focus 5:201\u2013204","journal-title":"Eur Urol Focus"},{"key":"369_CR190","first-page":"6172","volume":"55","author":"H Iwabuchi","year":"1995","unstructured":"Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW (1995) Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 55:6172\u20136180","journal-title":"Cancer Res"},{"key":"369_CR191","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","volume":"8","author":"MA Jafri","year":"2016","unstructured":"Jafri MA, Ansari SA, Alqahtani MH, Shay JW (2016) Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med 8:69","journal-title":"Genome Med"},{"key":"369_CR192","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074\u20131080","journal-title":"Science"},{"key":"369_CR193","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3803\/EnM.2016.31.1.100","volume":"31","author":"MJ Jeon","year":"2016","unstructured":"Jeon MJ, Kim WG, Sim S, Lim S, Kwon H, Kim TY, Shong YK, Kim WB (2016) Low prevalence of somatic TERT promoter mutations in classic papillary thyroid carcinoma. Endocrinol Metab (Seoul) 31:100\u2013104","journal-title":"Endocrinol Metab (Seoul)"},{"key":"369_CR194","first-page":"8213","volume":"14","author":"DE Jeong","year":"2017","unstructured":"Jeong DE, Woo SR, Nam H, Nam DH, Lee JH, Joo KM (2017) Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme. Oncol Lett 14:8213\u20138219","journal-title":"Oncol Lett"},{"key":"369_CR195","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12022-023-09778-w","volume":"34","author":"SI Jeong","year":"2023","unstructured":"Jeong SI, Kim W, Yu HW, Choi JY, Ahn CH, Moon JH, Choi SI, Cha W, Jeong WJ, Park SY, Na HY (2023) Incidence and clinicopathological features of differentiated high-grade thyroid carcinomas: an institutional experience. Endocr Pathol 34:287\u2013297","journal-title":"Endocr Pathol"},{"key":"369_CR196","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, Schulick RD, Tang LH, Wolfgang CL, Choti MA, Velculescu VE, Diaz LA Jr, Vogelstein B, Kinzler KW, Hruban RH, Papadopoulos N (2011) DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331:1199\u20131203","journal-title":"Science"},{"key":"369_CR197","doi-asserted-by":"publisher","first-page":"18346","DOI":"10.18632\/oncotarget.7811","volume":"7","author":"L Jin","year":"2016","unstructured":"Jin L, Chen E, Dong S, Cai Y, Zhang X, Zhou Y, Zeng R, Yang F, Pan C, Liu Y, Wu W, Xing M, Zhang X, Wang O (2016) BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients. Oncotarget 7:18346\u201318355","journal-title":"Oncotarget"},{"key":"369_CR198","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/cancers13040892","volume":"13","author":"M Jin","year":"2021","unstructured":"Jin M, Song DE, Ahn J, Song E, Lee YM, Sung TY, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim WG (2021) Genetic profiles of aggressive variants of papillary thyroid carcinomas. Cancers (Basel) 13:892","journal-title":"Cancers (Basel)"},{"key":"369_CR199","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1078-0432.CCR-18-0139","volume":"25","author":"S Job","year":"2019","unstructured":"Job S, Draskovic I, Burnichon N, Buffet A, Cros J, L\u00e9pine C, Venisse A, Robidel E, Verkarre V, Meatchi T, Sibony M, Amar L, Bertherat J, de Reyni\u00e8s A, Londo\u00f1o-Vallejo A, Favier J, Castro-Vega LJ, Gimenez-Roqueplo AP (2019) Telomerase activation and ATRX mutations are independent risk factors for metastatic Pheochromocytoma and Paraganglioma. Clin Cancer Res 25:760\u2013770","journal-title":"Clin Cancer Res"},{"key":"369_CR200","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1158\/1078-0432.CCR-05-0684","volume":"11","author":"JE Johnson","year":"2005","unstructured":"Johnson JE, Varkonyi RJ, Schwalm J, Cragle R, Klein-Szanto A, Patchefsky A, Cukierman E, von Mehren M, Broccoli D (2005) Multiple mechanisms of telomere maintenance exist in liposarcomas. Clin Cancer Res 11:5347\u20135355","journal-title":"Clin Cancer Res"},{"key":"369_CR201","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1126\/science.1063852","volume":"293","author":"PA Jones","year":"2001","unstructured":"Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068\u20131070","journal-title":"Science"},{"key":"369_CR202","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/path.5243","volume":"248","author":"NM Joseph","year":"2019","unstructured":"Joseph NM, Tsokos CG, Umetsu SE, Shain AH, Kelley RK, Onodera C, Bowman S, Talevich E, Ferrell LD, Kakar S, Krings G (2019) Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma. J Pathol 248:164\u2013178","journal-title":"J Pathol"},{"key":"369_CR203","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3892\/ol.2017.6284","volume":"14","author":"SJ Jung","year":"2017","unstructured":"Jung SJ, Kim DS, Park WJ, Lee H, Choi IJ, Park JY, Lee JH (2017) Mutation of the TERT promoter leads to poor prognosis of patients with non-small cell lung cancer. Oncol Lett 14:1609\u20131614","journal-title":"Oncol Lett"},{"key":"369_CR204","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2043-9113-3-6","volume":"3","author":"R Kala","year":"2013","unstructured":"Kala R, Peek GW, Hardy TM, Tollefsbol TO (2013) MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinforma 3:6","journal-title":"J Clin Bioinforma"},{"key":"369_CR205","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1111\/liv.14975","volume":"41","author":"HJ Kang","year":"2021","unstructured":"Kang HJ, Oh JH, Kim YW, Kim W, An J, Sung CO, Kim J, Shim JH, Hwang S, Yu E, Heaphy CM, Hong SM (2021) Clinicopathological and molecular characterization of chromophobe hepatocellular carcinoma. Liver Int 41:2499\u20132510","journal-title":"Liver Int"},{"key":"369_CR206","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.jpedsurg.2016.09.042","volume":"51","author":"M Kawashima","year":"2016","unstructured":"Kawashima M, Kojima M, Ueda Y, Kurihara S, Hiyama E (2016) Telomere biology including TERT rearrangements in neuroblastoma: a useful indicator for surgical treatments. J Pediatr Surg 51:2080\u20132085","journal-title":"J Pediatr Surg"},{"key":"369_CR207","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3390\/genes12111734","volume":"12","author":"T Kent","year":"2021","unstructured":"Kent T, Clynes D (2021) Alternative lengthening of telomeres: lessons to be learned from telomeric DNA double-strand break repair. Genes (Basel) 12:1734","journal-title":"Genes (Basel)"},{"key":"369_CR208","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Friedman AH, Friedman H, Gallia GL, Giovanella BC (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 110:6021\u20136026","journal-title":"Proc Natl Acad Sci USA"},{"key":"369_CR209","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.18632\/oncotarget.1765","volume":"5","author":"PJ Killela","year":"2014","unstructured":"Killela PJ, Pirozzi CJ, Healy P, Reitman ZJ, Lipp E, Rasheed BA, Yang R, Diplas BH, Wang Z, Greer PK, Zhu H, Wang CY, Carpenter AB, Friedman H, Friedman AH, Keir ST, He J, He Y, McLendon RE, Herndon JE 2nd, Yan H, Bigner DD (2014) Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget 5:1515\u20131525","journal-title":"Oncotarget"},{"key":"369_CR210","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1101\/gr.140301.112","volume":"23","author":"T-M Kim","year":"2013","unstructured":"Kim T-M, Xi R, Luquette LJ, Park RW, Johnson MD, Park PJ (2013) Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes. Genome Res 23:217\u2013227","journal-title":"Genome Res"},{"key":"369_CR211","first-page":"3501","volume":"35","author":"HS Kim","year":"2015","unstructured":"Kim HS, Lee HS, Nam KH, Choi J, Kim WH (2015) Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors. Anticancer Res 35:3501\u20133510","journal-title":"Anticancer Res"},{"key":"369_CR212","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1530\/ERC-16-0219","volume":"23","author":"TH Kim","year":"2016","unstructured":"Kim TH, Kim YE, Ahn S, Kim JY, Ki CS, Oh YL, Kim K, Yun JW, Park WY, Choe JH, Kim JH, Kim JS, Kim SW, Chung JH (2016) TERT promoter mutations and long-term survival in patients with thyroid cancer. Endocr Relat Cancer 23:813\u2013823","journal-title":"Endocr Relat Cancer"},{"key":"369_CR213","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12253-017-0275-6","volume":"24","author":"H Kim","year":"2017","unstructured":"Kim H, Ahn D, Sohn JH, Kim YH, Lee JH, Lee H (2017a) TERT promoter mutation and telomere length in salivary gland tumors. Pathol Oncol Res 24:697","journal-title":"Pathol Oncol Res"},{"key":"369_CR214","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1158\/1078-0432.CCR-16-1147","volume":"23","author":"JY Kim","year":"2017","unstructured":"Kim JY, Brosnan-Cashman JA, An S, Kim SJ, Song KB, Kim MS, Kim MJ, Hwang DW, Meeker AK, Yu E, Kim SC, Hruban RH, Heaphy CM, Hong SM (2017b) Alternative lengthening of telomeres in primary pancreatic neuroendocrine tumors is associated with aggressive clinical behavior and poor survival. Clin Cancer Res 23:1598\u20131606","journal-title":"Clin Cancer Res"},{"key":"369_CR215","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12020-017-1340-3","volume":"57","author":"TH Kim","year":"2017","unstructured":"Kim TH, Ki CS, Hahn SY, Oh YL, Jang HW, Kim SW, Chung JH, Shin JH (2017c) Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer. Endocrine 57:234\u2013240","journal-title":"Endocrine"},{"key":"369_CR216","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1210\/jc.2016-3434","volume":"102","author":"TH Kim","year":"2017","unstructured":"Kim TH, Ki CS, Kim HS, Kim K, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Jang HW, Kim SW, Chung JH (2017d) Refining dynamic risk stratification and prognostic groups for differentiated thyroid cancer with TERT promoter mutations. J Clin Endocrinol Metab 102:1757\u20131764","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR217","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4132\/jptm.2020.05.12","volume":"54","author":"SY Kim","year":"2020","unstructured":"Kim SY, Kim T, Kim K, Bae JS, Kim JS, Jung CK (2020) Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans. J Pathol Transl Med 54:310\u2013317","journal-title":"J Pathol Transl Med"},{"key":"369_CR218","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.3390\/cancers14194928","volume":"14","author":"MJ Kim","year":"2022","unstructured":"Kim MJ, Kim JK, Kim GJ, Kang SW, Lee J, Jeong JJ, Chung WY, Kim D, Nam KH (2022) TERT promoter and BRAF V600E mutations in papillary thyroid cancer: a single-institution experience in Korea. Cancers (Basel) 14:4928","journal-title":"Cancers (Basel)"},{"key":"369_CR219","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1158\/0008-5472.CAN-13-2498","volume":"73","author":"I Kinde","year":"2013","unstructured":"Kinde I, Munari E, Faraj SF, Hruban RH, Schoenberg M, Bivalacqua T, Allaf M, Springer S, Wang Y, Diaz LA Jr, Kinzler KW, Vogelstein B, Papadopoulos N, Netto GJ (2013) TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res 73:7162\u20137167","journal-title":"Cancer Res"},{"key":"369_CR220","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00401-013-1195-5","volume":"126","author":"C Koelsche","year":"2013","unstructured":"Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT, Kool M, Northcott PA, Wiestler B, Bohmer K, Meyer J, Mawrin C, Hartmann C, Mittelbronn M, Platten M, Brokinkel B, Seiz M, Herold-Mende C, Unterberg A, Schittenhelm J, Weller M, Pfister S, Wick W, Korshunov A, von Deimling A (2013) Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathol 126:907\u2013915","journal-title":"Acta Neuropathol"},{"key":"369_CR221","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1756-9966-33-33","volume":"33","author":"C Koelsche","year":"2014","unstructured":"Koelsche C, Renner M, Hartmann W, Brandt R, Lehner B, Waldburger N, Alldinger I, Schmitt T, Egerer G, Penzel R, Wardelmann E, Schirmacher P, von Deimling A, Mechtersheimer G (2014) TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities. J Exp Clin Cancer Res 33:33","journal-title":"J Exp Clin Cancer Res"},{"key":"369_CR222","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/his.12812","volume":"68","author":"C Koelsche","year":"2016","unstructured":"Koelsche C, Renner M, Johann P, Leiss I, Sahm F, Schimmack S, Wardelmann E, Renker EK, Schirmacher P, Korshunov A, von Deimling A, Mechtersheimer G (2016) Differential nuclear ATRX expression in sarcomas. Histopathology 68:738\u2013745","journal-title":"Histopathology"},{"key":"369_CR223","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ccr.2014.02.004","volume":"25","author":"M Kool","year":"2014","unstructured":"Kool M, Jones DT, Jager N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, Stark S, Hutter S, Seker-Cin H, Johann P, Bender S, Schmidt C, Rausch T, Shih D, Reimand J, Sieber L, Wittmann A, Linke L, Witt H, Weber UD, Zapatka M, Konig R, Beroukhim R, Bergthold G, van Sluis P, Volckmann R, Koster J, Versteeg R, Schmidt S, Wolf S, Lawerenz C, Bartholomae CC, von Kalle C, Unterberg A, Herold-Mende C, Hofer S, Kulozik AE, von Deimling A, Scheurlen W, Felsberg J, Reifenberger G, Hasselblatt M, Crawford JR, Grant GA, Jabado N, Perry A, Cowdrey C, Croul S, Zadeh G, Korbel JO, Doz F, Delattre O, Bader GD, McCabe MG, Collins VP, Kieran MW, Cho YJ, Pomeroy SL, Witt O, Brors B, Taylor MD, Schuller U, Korshunov A, Eils R, Wechsler-Reya RJ, Lichter P, Pfister SM, Project IPT (2014) Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25:393\u2013405","journal-title":"Cancer Cell"},{"key":"369_CR224","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1167\/iovs.14-14901","volume":"55","author":"AE Koopmans","year":"2014","unstructured":"Koopmans AE, Ober K, Dubbink HJ, Paridaens D, Naus NC, Belunek S, Krist B, Post E, Zwarthoff EC, de Klein A (2014) Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic LesionsRole of TERT promoter mutation in ocular melanoma. Invest Ophthalmol Vis Sci 55:6024\u20136030","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"369_CR225","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/bpa.12566","volume":"28","author":"A Korshunov","year":"2018","unstructured":"Korshunov A, Chavez L, Sharma T, Ryzhova M, Schrimpf D, Stichel D, Capper D, Sturm D, Kool M, Habel A, Kleinschmidt-DeMasters BK, Rosenblum M, Absalyamova O, Golanov A, Lichter P, Pfister SM, Jones DTW, Perry A, von Deimling A (2018) Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis. Brain Pathol 28:656\u2013662","journal-title":"Brain Pathol"},{"key":"369_CR226","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1245\/s10434-009-0333-8","volume":"16","author":"A Kumari","year":"2009","unstructured":"Kumari A, Srinivasan R, Vasishta RK, Wig JD (2009) Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer. Ann Surg Oncol 16:1051\u20131059","journal-title":"Ann Surg Oncol"},{"key":"369_CR227","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/cas.15256","volume":"113","author":"J Kunieda","year":"2022","unstructured":"Kunieda J, Yamashita K, Togashi Y, Baba S, Sakata S, Inamura K, Ae K, Matsumoto S, Machinami R, Kitagawa M, Takeuchi K (2022) High prevalence of TERT aberrations in myxoid liposarcoma: TERT reactivation may play a crucial role in tumorigenesis. Cancer Sci 113:1078\u20131089","journal-title":"Cancer Sci"},{"key":"369_CR228","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.anndiagpath.2015.12.002","volume":"21","author":"B Kurtis","year":"2016","unstructured":"Kurtis B, Zhuge J, Ojaimi C, Ye F, Cai D, Zhang D, Fallon JT, Zhong M (2016) Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications. Ann Diagn Pathol 21:7\u201311","journal-title":"Ann Diagn Pathol"},{"key":"369_CR229","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.surg.2020.04.054","volume":"169","author":"JH Kwon","year":"2021","unstructured":"Kwon JH, Yi JW (2021) Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma. Surgery 169:43\u201349","journal-title":"Surgery"},{"key":"369_CR230","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/j.1349-7006.2008.00878.x","volume":"99","author":"S Kyo","year":"2008","unstructured":"Kyo S, Takakura M, Fujiwara T, Inoue M (2008) Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99:1528\u20131538","journal-title":"Cancer Sci"},{"key":"369_CR231","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1212\/WNL.0000000000000814","volume":"83","author":"M Labussiere","year":"2014","unstructured":"Labussiere M, Boisselier B, Mokhtari K, Di Stefano AL, Rahimian A, Rossetto M, Ciccarino P, Saulnier O, Paterra R, Marie Y, Finocchiaro G, Sanson M (2014a) Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes. Neurology 83:1200\u20131206","journal-title":"Neurology"},{"key":"369_CR232","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/bjc.2014.538","volume":"111","author":"M Labussiere","year":"2014","unstructured":"Labussiere M, Di Stefano AL, Gleize V, Boisselier B, Giry M, Mangesius S, Bruno A, Paterra R, Marie Y, Rahimian A, Finocchiaro G, Houlston RS, Hoang-Xuan K, Idbaih A, Delattre JY, Mokhtari K, Sanson M (2014b) TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. Br J Cancer 111:2024\u20132032","journal-title":"Br J Cancer"},{"key":"369_CR233","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/genes7110093","volume":"7","author":"G Lam","year":"2016","unstructured":"Lam G, Xian RR, Li Y, Burns KH, Beemon KL (2016) Lack of TERT promoter mutations in human B-cell non-Hodgkin lymphoma. Genes (Basel) 7:93","journal-title":"Genes (Basel)"},{"key":"369_CR234","doi-asserted-by":"publisher","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","volume":"98","author":"I Landa","year":"2013","unstructured":"Landa I, Ganly I, Chan TA, Mitsutake N, Matsuse M, Ibrahimpasic T, Ghossein RA, Fagin JA (2013) Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab 98:E1562\u2013E1566","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR235","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA (2016) Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest 126:1052\u20131066","journal-title":"J Clin Invest"},{"key":"369_CR236","first-page":"1153","volume":"151","author":"ML Larramendy","year":"1997","unstructured":"Larramendy ML, Tarkkanen M, Blomqvist C, Virolainen M, Wiklund T, Asko-Seljavaara S, Elomaa I, Knuutila S (1997) Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 151:1153\u20131161","journal-title":"Am J Pathol"},{"key":"369_CR237","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12885-019-5424-8","volume":"19","author":"RT Lawlor","year":"2019","unstructured":"Lawlor RT, Veronese N, Pea A, Nottegar A, Smith L, Pilati C, Demurtas J, Fassan M, Cheng L, Luchini C (2019) Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis. BMC Cancer 19:232","journal-title":"BMC Cancer"},{"key":"369_CR238","doi-asserted-by":"publisher","first-page":"16641","DOI":"10.1038\/s41598-020-73642-8","volume":"10","author":"C Le Goux","year":"2020","unstructured":"Le Goux C, Vacher S, Schnitzler A, Barry Delongchamps N, Zerbib M, Peyromaure M, Sibony M, Allory Y, Bieche I, Damotte D, Pignot G (2020) Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer. Sci Rep 10:16641","journal-title":"Sci Rep"},{"key":"369_CR239","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/ijc.31935","volume":"144","author":"R Leao","year":"2019","unstructured":"Leao R, Lee D, Figueiredo A, Hermanns T, Wild P, Komosa M, Lau I, Mistry M, Nunes NM, Price AJ, Zhang C, Lipman T, Poyet C, Valtcheva N, Oehl K, Coelho H, Sayyid R, Gomes AM, Prado ECL, Sweet J, Vinagre J, Apolonio J, Stephens D, Faleiro I, Fadaak K, Richard PO, Kulkarni G, Zlotta AR, Hamilton RJ, Castelo-Branco P, Tabori U (2019) Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer. Int J Cancer 144:1676\u20131684","journal-title":"Int J Cancer"},{"key":"369_CR240","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/IGC.0b013e31823ca017","volume":"22","author":"YK Lee","year":"2012","unstructured":"Lee YK, Park NH, Lee H (2012) Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma. Int J Gynecol Cancer 22:434\u2013441","journal-title":"Int J Gynecol Cancer"},{"key":"369_CR241","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/modpathol.2015.67","volume":"28","author":"JC Lee","year":"2015","unstructured":"Lee JC, Jeng YM, Liau JY, Tsai JH, Hsu HH, Yang CY (2015a) Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas. Mod Pathol 28:1064\u20131073","journal-title":"Mod Pathol"},{"key":"369_CR242","doi-asserted-by":"publisher","first-page":"11200","DOI":"10.1038\/srep11200","volume":"5","author":"S Lee","year":"2015","unstructured":"Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A (2015b) TERT promoter mutations are predictive of aggressive clinical behavior in patients with Spitzoid melanocytic neoplasms. Sci Rep 5:11200","journal-title":"Sci Rep"},{"key":"369_CR243","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/pcmr.12471","volume":"29","author":"S Lee","year":"2016","unstructured":"Lee S, Opresko P, Pappo A, Kirkwood JM, Bahrami A (2016a) Association of TERT promoter mutations with telomerase expression in melanoma. Pigment Cell Melanoma Res 29:391\u2013393","journal-title":"Pigment Cell Melanoma Res"},{"key":"369_CR244","doi-asserted-by":"publisher","first-page":"69267","DOI":"10.18632\/oncotarget.12121","volume":"7","author":"SE Lee","year":"2016","unstructured":"Lee SE, Chang SH, Kim WY, Lim SD, Kim WS, Hwang TS, Han HS (2016b) Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma. Oncotarget 7:69267\u201369275","journal-title":"Oncotarget"},{"key":"369_CR245","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1089\/thy.2015.0488","volume":"26","author":"SE Lee","year":"2016","unstructured":"Lee SE, Hwang TS, Choi Y-L, Han HS, Kim WS, Jang MH, Kim SK, Yang JH (2016c) Prognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAFV600E mutation\u2013prevalent population. Thyroid 26:901\u2013910","journal-title":"Thyroid"},{"key":"369_CR246","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005766","volume":"96","author":"HW Lee","year":"2017","unstructured":"Lee HW, Park TI, Jang SY, Park SY, Park WJ, Jung SJ, Lee JH (2017a) Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma. Medicine (Baltimore) 96:e5766","journal-title":"Medicine (Baltimore)"},{"key":"369_CR247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-016-2349-9","volume":"132","author":"J Lee","year":"2017","unstructured":"Lee J, Solomon DA, Tihan T (2017b) The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children. J Neuro-Oncol 132:1\u201311","journal-title":"J Neuro-Oncol"},{"key":"369_CR248","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40478-017-0465-1","volume":"5","author":"Y Lee","year":"2017","unstructured":"Lee Y, Koh J, Kim SI, Won JK, Park CK, Choi SH, Park SH (2017c) The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta Neuropathol Commun 5:62","journal-title":"Acta Neuropathol Commun"},{"key":"369_CR249","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1111\/liv.15356","volume":"42","author":"HW Lee","year":"2022","unstructured":"Lee HW, Kim E, Cho KJ, Park HJ, Seo J, Lee H, Baek E, Choi JR, Han KH, Lee ST, Park JY (2022) Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma. Liver Int 42:2317\u20132326","journal-title":"Liver Int"},{"key":"369_CR250","first-page":"5086","volume":"54","author":"NA Levin","year":"1994","unstructured":"Levin NA, Brzoska P, Gupta N, Minna JD, Gray JW, Christman MF (1994) Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res 54:5086\u20135091","journal-title":"Cancer Res"},{"key":"369_CR251","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/gcc.2870130307","volume":"13","author":"NA Levin","year":"1995","unstructured":"Levin NA, Bnorka PM, Warnock ML, Gray JW, Christman MF (1995) Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes Cancer 13:175\u2013185","journal-title":"Genes Chromosomes Cancer"},{"key":"369_CR252","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fgene.2016.00083","volume":"7","author":"KA Lewis","year":"2016","unstructured":"Lewis KA, Tollefsbol TO (2016) Regulation of the telomerase reverse transcriptase subunit through epigenetic mechanisms. Front Genet 7:83","journal-title":"Front Genet"},{"key":"369_CR253","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059064","volume":"8","author":"X Li","year":"2013","unstructured":"Li X, Yao X, Wang Y, Hu F, Wang F, Jiang L, Liu Y, Wang D, Sun G, Zhao Y (2013) MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS One 8:e59064","journal-title":"PLoS One"},{"key":"369_CR254","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107276","volume":"9","author":"C Li","year":"2014","unstructured":"Li C, Hao L, Li Y, Wang S, Chen H, Zhang L, Ke B, Yin Y, Suo H, Sun B, Zhang B, Wang C (2014) Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer. PLoS One 9:e107276","journal-title":"PLoS One"},{"key":"369_CR255","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13000-020-00962-8","volume":"15","author":"M Li","year":"2020","unstructured":"Li M, Jia H, Qian Q, Wen P, Chen C, Hua Y, Wang K, Zhang W, Shi F (2020) Genomic characterization of high-recurrence risk papillary thyroid carcinoma in a southern Chinese population. Diagn Pathol 15:49","journal-title":"Diagn Pathol"},{"key":"369_CR256","doi-asserted-by":"publisher","first-page":"538927","DOI":"10.3389\/fonc.2021.538927","volume":"11","author":"DY Li","year":"2021","unstructured":"Li DY, Yang F, Liao WQ, Zhou XF, Li WB, Cai JR, Liu BL, Luo Y, Zhan HL (2021) Deep genomic sequencing of bladder urothelial carcinoma in southern Chinese patients: a single-center study. Front Oncol 11:538927","journal-title":"Front Oncol"},{"key":"369_CR257","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/path.5005","volume":"244","author":"J Liang","year":"2018","unstructured":"Liang J, Cai W, Feng D, Teng H, Mao F, Jiang Y, Hu S, Li X, Zhang Y, Liu B, Sun ZS (2018) Genetic landscape of papillary thyroid carcinoma in the Chinese population. J Pathol 244:215\u2013226","journal-title":"J Pathol"},{"key":"369_CR258","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/cup.12323","volume":"41","author":"JY Liau","year":"2014","unstructured":"Liau JY, Tsai JH, Jeng YM, Chu CY, Kuo KT, Liang CW (2014) TERT promoter mutation is uncommon in acral lentiginous melanoma. J Cutan Pathol 41:504\u2013508","journal-title":"J Cutan Pathol"},{"key":"369_CR259","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/modpathol.2015.114","volume":"28","author":"JY Liau","year":"2015","unstructured":"Liau JY, Lee JC, Tsai JH, Yang CY, Liu TL, Ke ZL, Hsu HH, Jeng YM (2015a) Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas. Mod Pathol 28:1545\u20131554","journal-title":"Mod Pathol"},{"key":"369_CR260","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/PAS.0000000000000324","volume":"39","author":"JY Liau","year":"2015","unstructured":"Liau JY, Tsai JH, Jeng YM, Lee JC, Hsu HH, Yang CY (2015b) Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome. Am J Surg Pathol 39:236\u2013244","journal-title":"Am J Surg Pathol"},{"key":"369_CR261","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.humpath.2015.05.019","volume":"46","author":"JY Liau","year":"2015","unstructured":"Liau JY, Tsai JH, Yang CY, Lee JC, Liang CW, Hsu HH, Jeng YM (2015c) Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas. Hum Pathol 46:1360\u20131366","journal-title":"Hum Pathol"},{"key":"369_CR262","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/bjophthalmol-2015-307503","volume":"100","author":"SY Lin","year":"2016","unstructured":"Lin SY, Liao SL, Hong JB, Chu CY, Sheen YS, Jhuang JY, Tsai JH, Liau JY (2016) TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis. Br J Ophthalmol 100:274\u2013277","journal-title":"Br J Ophthalmol"},{"key":"369_CR263","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3892\/br.2015.463","volume":"3","author":"S Lindner","year":"2015","unstructured":"Lindner S, Bachmann HS, Odersky A, Schaefers S, Klein-Hitpass L, Hero B, Fischer M, Eggert A, Schramm A, Schulte JH (2015) Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma. Biomed Rep 3:443\u2013446","journal-title":"Biomed Rep"},{"key":"369_CR264","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1225-3","volume":"127","author":"JC Lindsey","year":"2014","unstructured":"Lindsey JC, Schwalbe EC, Potluri S, Bailey S, Williamson D, Clifford SC (2014) TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours. Acta Neuropathol 127:307\u2013309","journal-title":"Acta Neuropathol"},{"key":"369_CR265","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1530\/ERC-14-0359","volume":"21","author":"R Liu","year":"2014","unstructured":"Liu R, Xing M (2014) Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy. Endocr Relat Cancer 21:825\u2013830","journal-title":"Endocr Relat Cancer"},{"key":"369_CR266","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1158\/0008-5472.CAN-06-4126","volume":"67","author":"C Liu","year":"2007","unstructured":"Liu C, Fang XL, Ge Z, Jalink M, Kyo S, Bjorkhom M, Gruber A, Sjoberg J, Xu DW (2007) The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Cancer Res 67:2626\u20132631","journal-title":"Cancer Res"},{"key":"369_CR267","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1746-1596-7-147","volume":"7","author":"H Liu","year":"2012","unstructured":"Liu H, Liu S, Wang H, Xie X, Chen X, Zhang X, Zhang Y (2012a) Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Diagn Pathol 7:147","journal-title":"Diagn Pathol"},{"key":"369_CR268","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1746-1596-7-147","volume":"7","author":"HQ Liu","year":"2012","unstructured":"Liu HQ, Liu SL, Wang H, Xie XY, Chen XL, Zhang XM, Zhang YC (2012b) Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Diagn Pathol 7:147","journal-title":"Diagn Pathol"},{"key":"369_CR269","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/ERC-13-0210","volume":"20","author":"X Liu","year":"2013","unstructured":"Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M (2013a) Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20:603\u2013610","journal-title":"Endocr Relat Cancer"},{"key":"369_CR270","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.4161\/cc.24662","volume":"12","author":"X Liu","year":"2013","unstructured":"Liu X, Wu G, Shan Y, Hartmann C, von Deimling A, Xing M (2013b) Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma. Cell Cycle 12:1637\u20131638","journal-title":"Cell Cycle"},{"key":"369_CR271","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/ERC-14-0016","volume":"21","author":"T Liu","year":"2014","unstructured":"Liu T, Brown TC, Juhlin CC, Andreasson A, Wang N, Backdahl M, Healy JM, Prasad ML, Korah R, Carling T, Xu D, Larsson C (2014a) The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors. Endocr Relat Cancer 21:427\u2013434","journal-title":"Endocr Relat Cancer"},{"key":"369_CR272","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.gene.2014.02.051","volume":"540","author":"T Liu","year":"2014","unstructured":"Liu T, Liang X, Bjorkholm M, Jia J, Xu D (2014b) The absence of TERT promoter mutations in primary gastric cancer. Gene 540:266\u2013267","journal-title":"Gene"},{"key":"369_CR273","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1038\/onc.2013.446","volume":"33","author":"T Liu","year":"2014","unstructured":"Liu T, Wang N, Cao J, Sofiadis A, Dinets A, Zedenius J, Larsson C, Xu D (2014c) The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas. Oncogene 33:4978\u20134984","journal-title":"Oncogene"},{"key":"369_CR274","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13107","volume":"32","author":"EM Liu","year":"2022","unstructured":"Liu EM, Shi ZF, Li KK, Malta TM, Chung NY, Chen H, Chan JY, Poon MF, Kwan JS, Chan DT, Noushmehr H, Mao Y, Ng HK (2022) Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas. Brain Pathol 32:e13107","journal-title":"Brain Pathol"},{"key":"369_CR275","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3892\/ol.2020.11332","volume":"19","author":"D Lombardo","year":"2020","unstructured":"Lombardo D, Saitta C, Giosa D, Di Tocco FC, Musolino C, Caminiti G, Chines V, Franz\u00e8 MS, Alibrandi A, Navarra G, Raimondo G, Pollicino T (2020) Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from southern Italy. Oncol Lett 19:2368\u20132374","journal-title":"Oncol Lett"},{"key":"369_CR276","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1038\/ncomms5723","volume":"5","author":"I Lopez de Silanes","year":"2014","unstructured":"Lopez de Silanes I, Grana O, De Bonis ML, Dominguez O, Pisano DG, Blasco MA (2014) Identification of TERRA locus unveils a telomere protection role through association to nearly all chromosomes. Nat Commun 5:4723","journal-title":"Nat Commun"},{"key":"369_CR277","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00401-018-1906-z","volume":"137","author":"GY L\u00f3pez","year":"2019","unstructured":"L\u00f3pez GY, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Clarke J, Oberheim Bush NA, Taylor J, Chang S, Butowski N, Banerjee A, Mueller S, Kline C, Torkildson J, Samuel D, Siongco A, Raffel C, Gupta N, Kunwar S, Mummaneni P, Aghi M, Theodosopoulos P, Berger M, Phillips JJ, Pekmezci M, Tihan T, Bollen AW, Perry A, Solomon DA (2019) The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathol 137:139\u2013150","journal-title":"Acta Neuropathol"},{"key":"369_CR278","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194\u20131217","journal-title":"Cell"},{"key":"369_CR279","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.tibs.2013.07.001","volume":"38","author":"KC Low","year":"2013","unstructured":"Low KC, Tergaonkar V (2013) Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochem Sci 38:426\u2013434","journal-title":"Trends Biochem Sci"},{"key":"369_CR280","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-018-03067-x","volume":"142","author":"VM Lu","year":"2019","unstructured":"Lu VM, Goyal A, Lee A, Jentoft M, Quinones-Hinojosa A, Chaichana KL (2019) The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis. J Neuro-Oncol 142:1\u201310","journal-title":"J Neuro-Oncol"},{"key":"369_CR281","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1038\/emboj.2009.166","volume":"28","author":"B Luke","year":"2009","unstructured":"Luke B, Lingner J (2009) TERRA: telomeric repeat-containing RNA. EMBO J 28:2503\u20132510","journal-title":"EMBO J"},{"key":"369_CR282","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/gcc.20850","volume":"50","author":"G Lundberg","year":"2011","unstructured":"Lundberg G, Sehic D, Lansberg JK, Ora I, Frigyesi A, Castel V, Navarro S, Piqueras M, Martinsson T, Noguera R, Gisselsson D (2011) Alternative lengthening of telomeres \u2013 an enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas. Genes Chromosomes Cancer 50:250\u2013262","journal-title":"Genes Chromosomes Cancer"},{"key":"369_CR283","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0092-8674(93)90234-H","volume":"73","author":"V Lundblad","year":"1993","unstructured":"Lundblad V, Blackburn EH (1993) An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell 73:347\u2013360","journal-title":"Cell"},{"key":"369_CR284","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.lungcan.2014.10.009","volume":"86","author":"X Ma","year":"2014","unstructured":"Ma X, Gong R, Wang R, Pan Y, Cai D, Pan B, Li Y, Xiang J, Li H, Zhang J, Sun Y, Chen H (2014) Recurrent TERT promoter mutations in non-small cell lung cancers. Lung Cancer 86:369\u2013373","journal-title":"Lung Cancer"},{"key":"369_CR285","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1016\/j.wneu.2018.09.050","volume":"120","author":"C Ma","year":"2018","unstructured":"Ma C, Feng R, Chen H, Hameed NUF, Aibaidula A, Song Y, Wu J (2018) BRAF V600E, TERT, and IDH2 mutations in pleomorphic Xanthoastrocytoma: observations from a large case-series study. World Neurosurg 120:e1225\u2013e1233","journal-title":"World Neurosurg"},{"key":"369_CR286","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00428-015-1784-x","volume":"467","author":"E Macerola","year":"2015","unstructured":"Macerola E, Loggini B, Giannini R, Garavello G, Giordano M, Proietti A, Niccoli C, Basolo F, Fontanini G (2015) Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness. Virchows Arch 467:177\u2013184","journal-title":"Virchows Arch"},{"key":"369_CR287","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/genes7090064","volume":"7","author":"DE MacNeil","year":"2016","unstructured":"MacNeil DE, Bensoussan HJ, Autexier C (2016) Telomerase regulation from beginning to the end. Genes (Basel) 7:64","journal-title":"Genes (Basel)"},{"key":"369_CR288","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00401-014-1348-1","volume":"128","author":"J Mangerel","year":"2014","unstructured":"Mangerel J, Price A, Castelo-Branco P, Brzezinski J, Buczkowicz P, Rakopoulos P, Merino D, Baskin B, Wasserman J, Mistry M, Barszczyk M, Picard D, Mack S, Remke M, Starkman H, Elizabeth C, Zhang C, Alon N, Lees J, Andrulis IL, Wunder JS, Jabado N, Johnston DL, Rutka JT, Dirks PB, Bouffet E, Taylor MD, Huang A, Malkin D, Hawkins C, Tabori U (2014) Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors. Acta Neuropathol 128:853\u2013862","journal-title":"Acta Neuropathol"},{"key":"369_CR289","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/bjd.19297","volume":"184","author":"E Manrique-Silva","year":"2021","unstructured":"Manrique-Silva E, Rachakonda S, Mill\u00e1n-Esteban D, Garc\u00eda-Casado Z, Requena C, Trav\u00e9s V, Kumar R, Nagore E (2021) Clinical, environmental and histological distribution of BRAF, NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients. Br J Dermatol 184:504\u2013513","journal-title":"Br J Dermatol"},{"key":"369_CR290","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","volume":"146","author":"I Marinoni","year":"2014","unstructured":"Marinoni I, Kurrer AS, Vassella E, Dettmer M, Rudolph T, Banz V, Hunger F, Pasquinelli S, Speel EJ, Perren A (2014) Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 146:453\u2013460","journal-title":"Gastroenterology"},{"key":"369_CR291","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc3025","volume":"11","author":"P Martinez","year":"2011","unstructured":"Martinez P, Blasco MA (2011) Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11:161\u2013176","journal-title":"Nat Rev Cancer"},{"key":"369_CR292","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s40618-016-0479-8","volume":"39","author":"CS Martins","year":"2016","unstructured":"Martins CS, de Castro M, Calado RT (2016) Absence of TERT promoter mutations in pituitary adenomas. J Endocrinol Investig 39:933\u2013934","journal-title":"J Endocrinol Investig"},{"key":"369_CR293","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.trsl.2013.08.009","volume":"162","author":"PJ Mason","year":"2013","unstructured":"Mason PJ, Perdigones N (2013) Telomere biology and translational research. Transl Res 162:333\u2013342","journal-title":"Transl Res"},{"key":"369_CR294","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2106\/JBJS.G.01390","volume":"91","author":"T Matsuo","year":"2009","unstructured":"Matsuo T, Shay JW, Wright WE, Hiyama E, Shimose S, Kubo T, Sugita T, Yasunaga Y, Ochi M (2009) Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas. J Bone Joint Surg Am 91:928\u2013937","journal-title":"J Bone Joint Surg Am"},{"key":"369_CR295","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.1038\/s41598-020-65057-2","volume":"10","author":"MG Maturo","year":"2020","unstructured":"Maturo MG, Rachakonda S, Heidenreich B, Pellegrini C, Srinivas N, Requena C, Serra-Guillen C, Llombart B, Sanmartin O, Guillen C, Di Nardo L, Peris K, Fargnoli MC, Nagore E, Kumar R (2020) Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma. Sci Rep 10:8005","journal-title":"Sci Rep"},{"key":"369_CR296","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/NEN.0b013e3181e576cf","volume":"69","author":"KL McDonald","year":"2010","unstructured":"McDonald KL, McDonnell J, Muntoni A, Henson JD, Hegi ME, von Deimling A, Wheeler HR, Cook RJ, Biggs MT, Little NS, Robinson BG, Reddel RR, Royds JA (2010) Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol 69:729\u2013736","journal-title":"J Neuropathol Exp Neurol"},{"key":"369_CR297","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/path.5333","volume":"249","author":"ND Md Nasir","year":"2019","unstructured":"Md Nasir ND, Ng CCY, Rajasegaran V, Wong SF, Liu W, Ng GXP, Lee JY, Guan P, Lim JQ, Thike AA, Koh VCY, Loke BN, Chang KTE, Gudi MA, Lian DWQ, Madhukumar P, Tan BKT, Tan VKM, Wong CY, Yong WS, Ho GH, Ong KW, Tan P, Teh BT, Tan PH (2019) Genomic characterisation of breast fibroepithelial lesions in an international cohort. J Pathol 249:447\u2013460","journal-title":"J Pathol"},{"key":"369_CR298","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1210\/jc.2013-3734","volume":"99","author":"M Melo","year":"2014","unstructured":"Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Maximo V, Sobrinho-Simoes M, Soares P (2014) TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab 99:E754\u2013E765","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR299","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1210\/jc.2016-2785","volume":"102","author":"M Melo","year":"2017","unstructured":"Melo M, Gaspar da Rocha A, Batista R, Vinagre J, Martins MJ, Costa G, Ribeiro C, Carrilho F, Leite V, Lobo C, Cameselle-Teijeiro JM, Cavadas B, Pereira L, Sobrinho-Simoes M, Soares P (2017) TERT, BRAF, and NRAS in primary thyroid cancer and metastatic disease. J Clin Endocrinol Metab 102:1898\u20131907","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR300","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11060-019-03127-w","volume":"142","author":"S Minasi","year":"2019","unstructured":"Minasi S, Baldi C, Pietsch T, Donofrio V, Pollo B, Antonelli M, Massimino M, Giangaspero F, Buttarelli FR (2019) Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood. J Neuro-Oncol 142:435\u2013444","journal-title":"J Neuro-Oncol"},{"key":"369_CR301","doi-asserted-by":"publisher","first-page":"12534","DOI":"10.1038\/ncomms12534","volume":"7","author":"JJ Montero","year":"2016","unstructured":"Montero JJ, Lopez de Silanes I, Grana O, Blasco MA (2016) Telomeric RNAs are essential to maintain telomeres. Nat Commun 7:12534","journal-title":"Nat Commun"},{"key":"369_CR302","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/jcp-2023-209005","volume":"77","author":"JO Mori","year":"2023","unstructured":"Mori JO, Keegan J, Flynn RL, Heaphy CM (2023) Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer. J Clin Pathol 77:82","journal-title":"J Clin Pathol"},{"key":"369_CR303","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrg3722","volume":"15","author":"KV Morris","year":"2014","unstructured":"Morris KV, Mattick JS (2014) The rise of regulatory RNA. Nat Rev Genet 15:423\u2013437","journal-title":"Nat Rev Genet"},{"key":"369_CR304","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11060-018-03044-4","volume":"141","author":"RA Morshed","year":"2019","unstructured":"Morshed RA, Han SJ, Hervey-Jumper SL, Pekmezci M, Troncon I, Chang SM, Butowski NA, Berger MS (2019) Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60. J Neuro-Oncol 141:383\u2013391","journal-title":"J Neuro-Oncol"},{"key":"369_CR305","doi-asserted-by":"publisher","first-page":"16663","DOI":"10.18632\/oncotarget.4389","volume":"6","author":"MA Mosrati","year":"2015","unstructured":"Mosrati MA, Malmstrom A, Lysiak M, Krysztofiak A, Hallbeck M, Milos P, Hallbeck AL, Bratthall C, Strandeus M, Stenmark-Askmalm M, Soderkvist P (2015a) TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma. Oncotarget 6:16663\u201316673","journal-title":"Oncotarget"},{"key":"369_CR306","doi-asserted-by":"publisher","first-page":"25109","DOI":"10.18632\/oncotarget.4668","volume":"6","author":"MA Mosrati","year":"2015","unstructured":"Mosrati MA, Willander K, Falk IJ, Hermanson M, Hoglund M, Stockelberg D, Wei Y, Lotfi K, Soderkvist P (2015b) Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis. Oncotarget 6:25109\u201325120","journal-title":"Oncotarget"},{"key":"369_CR307","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.mce.2014.10.019","volume":"399","author":"M Muzza","year":"2015","unstructured":"Muzza M, Colombo C, Rossi S, Tosi D, Cirello V, Perrino M, De Leo S, Magnani E, Pignatti E, Vigo B, Simoni M, Bulfamante G, Vicentini L, Fugazzola L (2015) Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization. Mol Cell Endocrinol 399:288\u2013295","journal-title":"Mol Cell Endocrinol"},{"key":"369_CR308","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4143\/crt.2015.362","volume":"48","author":"JK Myung","year":"2016","unstructured":"Myung JK, Kwak BK, Lim JA, Lee MC, Kim MJ (2016) TERT promoter mutations and tumor persistence\/recurrence in papillary thyroid cancer. Cancer Res Treat 48:942\u2013947","journal-title":"Cancer Res Treat"},{"key":"369_CR309","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/cen.14728","volume":"97","author":"HY Na","year":"2022","unstructured":"Na HY, Yu HW, Kim W, Moon JH, Ahn CH, Choi SI, Kim YK, Choi JY, Park SY (2022) Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma. Clin Endocrinol 97:106\u2013115","journal-title":"Clin Endocrinol"},{"key":"369_CR310","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/genes8050145","volume":"8","author":"E Naderlinger","year":"2017","unstructured":"Naderlinger E, Holzmann K (2017) Epigenetic regulation of telomere maintenance for therapeutic interventions in gliomas. Genes (Basel) 8:145","journal-title":"Genes (Basel)"},{"key":"369_CR311","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ijc.30042","volume":"139","author":"E Nagore","year":"2016","unstructured":"Nagore E, Heidenreich B, Rachakonda S, Garcia-Casado Z, Requena C, Soriano V, Frank C, Traves V, Quecedo E, Sanjuan-Gimenez J, Hemminki K, Landi MT, Kumar R (2016a) TERT promoter mutations in melanoma survival. Int J Cancer 139:75\u201384","journal-title":"Int J Cancer"},{"key":"369_CR312","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12441","volume":"29","author":"E Nagore","year":"2016","unstructured":"Nagore E, Heidenreich B, Requena C, Garcia-Casado Z, Martorell-Calatayud A, Pont-Sanjuan V, Jimenez-Sanchez AI, Kumar R (2016b) TERT promoter mutations associate with fast-growing melanoma. Pigment Cell Melanoma Res 29:236\u2013238","journal-title":"Pigment Cell Melanoma Res"},{"key":"369_CR313","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/cen.14567","volume":"95","author":"T Nakao","year":"2021","unstructured":"Nakao T, Matsuse M, Saenko V, Rogounovitch T, Tanaka A, Suzuki K, Higuchi M, Sasai H, Sano T, Hirokawa M, Miyauchi A, Kawakami A, Mitsutake N (2021) Preoperative detection of the TERT promoter mutations in papillary thyroid carcinomas. Clin Endocrinol 95:790\u2013799","journal-title":"Clin Endocrinol"},{"key":"369_CR314","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrm3505","volume":"14","author":"J Nandakumar","year":"2013","unstructured":"Nandakumar J, Cech TR (2013) Finding the end: recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol 14:69\u201382","journal-title":"Nat Rev Mol Cell Biol"},{"key":"369_CR315","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/ncomms3218","volume":"4","author":"JC Nault","year":"2013","unstructured":"Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J (2013) High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 4:2218","journal-title":"Nat Commun"},{"key":"369_CR316","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/hep.27372","volume":"60","author":"JC Nault","year":"2014","unstructured":"Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, Roncalli M, Zucman-Rossi J (2014) Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology 60:1983\u20131992","journal-title":"Hepatology"},{"key":"369_CR317","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.30811","volume":"71","author":"JC Nault","year":"2020","unstructured":"Nault JC, Martin Y, Caruso S, Hirsch TZ, Bayard Q, Calderaro J, Charpy C, Copie-Bergman C, Ziol M, Bioulac-Sage P, Couchy G, Blanc JF, Nahon P, Amaddeo G, Ganne-Carrie N, Morcrette G, Chiche L, Duvoux C, Faivre S, Laurent A, Imbeaud S, Rebouissou S, Llovet JM, Seror O, Letouz\u00e9 E, Zucman-Rossi J (2020) Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma. Hepatology 71:164\u2013182","journal-title":"Hepatology"},{"key":"369_CR318","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11060-015-1999-3","volume":"126","author":"U Nencha","year":"2016","unstructured":"Nencha U, Rahimian A, Giry M, Sechi A, Mokhtari K, Polivka M, Schmitt Y, Di Stefano AL, Alentorn A, Labussiere M, Sanson M (2016) TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas. J Neuro-Oncol 126:441\u2013446","journal-title":"J Neuro-Oncol"},{"key":"369_CR319","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1101\/gad.205062.112","volume":"27","author":"AA Neumann","year":"2013","unstructured":"Neumann AA, Watson CM, Noble JR, Pickett HA, Tam PP, Reddel RR (2013) Alternative lengthening of telomeres in normal mammalian somatic cells. Genes Dev 27:18\u201323","journal-title":"Genes Dev"},{"key":"369_CR320","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/his.14996","volume":"83","author":"A Neyaz","year":"2023","unstructured":"Neyaz A, Crotty R, Rickelt S, Pankaj A, Stojanova M, Michelakos TP, Sekigami Y, Kontos F, Parrack PH, Patil DT, Heaphy CM, Ferrone CR, Deshpande V (2023) Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT). Histopathology 83:546\u2013558","journal-title":"Histopathology"},{"key":"369_CR321","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13120","volume":"33","author":"HK Ng","year":"2023","unstructured":"Ng HK, Li KK, Chung NY, Chan JY, Poon MF, Wong QH, Kwan JS, Poon WS, Chen H, Chan DT, Shi ZF, Mao Y (2023) Molecular landscapes of longitudinal NF2\/22q and non-NF2\/22q meningiomas show different life histories. Brain Pathol 33:e13120","journal-title":"Brain Pathol"},{"key":"369_CR322","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1750-3639.2012.00630.x","volume":"23","author":"DN Nguyen","year":"2013","unstructured":"Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG, Meeker AK, Rodriguez FJ (2013) Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol 23:237\u2013243","journal-title":"Brain Pathol"},{"key":"369_CR323","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00428-016-2001-2","volume":"469","author":"D Nguyen","year":"2016","unstructured":"Nguyen D, Taheri D, Springer S, Cowan M, Guner G, Mendoza Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Ricardo BF, Cunha I, Fujita K, Ertoy D, Kinzler KW, Bivalacqua TJ, Papadopoulos N, Vogelstein B, Netto GJ (2016) High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma. Virchows Arch 469:427\u2013434","journal-title":"Virchows Arch"},{"key":"369_CR324","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ajcp\/aqx166","volume":"149","author":"K Nishikimi","year":"2018","unstructured":"Nishikimi K, Nakagawa K, Tate S, Matsuoka A, Iwamoto M, Kiyokawa T, Shozu M (2018) Uncommon human telomerase reverse transcriptase promoter mutations are associated with poor survival in ovarian clear cell carcinoma. Am J Clin Pathol 149:352\u2013361","journal-title":"Am J Clin Pathol"},{"key":"369_CR325","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00401-013-1163-0","volume":"126","author":"N Nonoguchi","year":"2013","unstructured":"Nonoguchi N, Ohta T, Oh JE, Kim YH, Kleihues P, Ohgaki H (2013) TERT promoter mutations in primary and secondary glioblastomas. Acta Neuropathol 126:931\u2013937","journal-title":"Acta Neuropathol"},{"key":"369_CR326","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/molehr\/gaw053","volume":"22","author":"B Novakovic","year":"2016","unstructured":"Novakovic B, Napier CE, Vryer R, Dimitriadis E, Manuelpillai U, Sharkey A, Craig JM, Reddel RR, Saffery R (2016) DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta. Mol Hum Reprod 22:791\u2013799","journal-title":"Mol Hum Reprod"},{"key":"369_CR327","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10549-017-4156-1","volume":"162","author":"S Nozad","year":"2017","unstructured":"Nozad S, Sheehan CE, Gay LM, Elvin JA, Vergilio JA, Suh J, Ramkissoon S, Schrock AB, Hirshfield KM, Ali N, Ganesan S, Ali SM, Miller VA, Stephens PJ, Ross JS, Chung JH (2017) Comprehensive genomic profiling of malignant phyllodes tumors of the breast. Breast Cancer Res Treat 162:597\u2013602","journal-title":"Breast Cancer Res Treat"},{"key":"369_CR328","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00432-016-2322-1","volume":"143","author":"R Ofner","year":"2017","unstructured":"Ofner R, Ritter C, Heidenreich B, Kumar R, Ugurel S, Schrama D, Becker JC (2017) Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients. J Cancer Res Clin Oncol 143:613\u2013617","journal-title":"J Cancer Res Clin Oncol"},{"key":"369_CR329","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/gcc.20600","volume":"47","author":"A Ohali","year":"2008","unstructured":"Ohali A, Avigad S, Naumov I, Goshen Y, Ash S, Yaniv I (2008) Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma. Genes Chromosomes Cancer 47:965\u2013970","journal-title":"Genes Chromosomes Cancer"},{"key":"369_CR330","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0378-1119(02)01156-3","volume":"303","author":"T Oikawa","year":"2003","unstructured":"Oikawa T, Yamada T (2003) Molecular biology of the Ets family of transcription factors. Gene 303:11\u201334","journal-title":"Gene"},{"key":"369_CR331","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/modpathol.2017.75","volume":"30","author":"N Oishi","year":"2017","unstructured":"Oishi N, Kondo T, Ebina A, Sato Y, Akaishi J, Hino R, Yamamoto N, Mochizuki K, Nakazawa T, Yokomichi H, Ito K, Ishikawa Y, Katoh R (2017) Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation. Mod Pathol 30:1527\u20131537","journal-title":"Mod Pathol"},{"key":"369_CR332","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1349-7006.2008.01063.x","volume":"100","author":"Y Omori","year":"2009","unstructured":"Omori Y, Nakayama F, Li D, Kanemitsu K, Semba S, Ito A, Yokozaki H (2009) Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient gastric carcinoma. Cancer Sci 100:413\u2013418","journal-title":"Cancer Sci"},{"key":"369_CR333","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12022-016-9420-0","volume":"27","author":"S Onder","year":"2016","unstructured":"Onder S, Ozturk Sari S, Yegen G, Sormaz IC, Yilmaz I, Poyrazoglu S, Sanli Y, Giles Senyurek Y, Kapran Y, Mete O (2016) Classic architecture with multicentricity and local recurrence, and absence of TERT promoter mutations are correlates of BRAF (V600E) harboring pediatric papillary thyroid carcinomas. Endocr Pathol 27:153\u2013161","journal-title":"Endocr Pathol"},{"key":"369_CR334","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.jpedsurg.2009.07.046","volume":"44","author":"Y Onitake","year":"2009","unstructured":"Onitake Y, Hiyama E, Kamei N, Yamaoka H, Sueda T, Hiyama K (2009) Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres. J Pediatr Surg 44:2258\u20132266","journal-title":"J Pediatr Surg"},{"key":"369_CR335","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2176\/nmc.oa.2020-0155","volume":"60","author":"T Ono","year":"2020","unstructured":"Ono T, Sasajima T, Shimizu H, Natsumeda M, Kanamori M, Asano K, Beppu T, Matsuda K, Ichikawa M, Fujii Y, Ohkuma H, Ogasawara K, Sonoda Y, Saito K, Nobusawa S, Nakazato Y, Kitanaka C, Kayama T, Tominaga T (2020) Molecular features and prognostic factors of pleomorphic Xanthoastrocytoma: a collaborative investigation of the Tohoku brain tumor study group. Neurol Med Chir (Tokyo) 60:543\u2013552","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"369_CR336","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1242\/jcs.148296","volume":"128","author":"S Osterwald","year":"2015","unstructured":"Osterwald S, Deeg KI, Chung I, Parisotto D, Worz S, Rohr K, Erfle H, Rippe K (2015) PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening. J Cell Sci 128:1887\u20131900","journal-title":"J Cell Sci"},{"key":"369_CR337","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrm2848","volume":"11","author":"RJ O\u2019Sullivan","year":"2010","unstructured":"O\u2019Sullivan RJ, Karlseder J (2010) Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 11:171\u2013181","journal-title":"Nat Rev Mol Cell Biol"},{"key":"369_CR338","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.eururo.2017.05.033","volume":"73","author":"SK Pal","year":"2018","unstructured":"Pal SK, Ali SM, Yakirevich E, Geynisman DM, Karam JA, Elvin JA, Frampton GM, Huang X, Lin DI, Rosenzweig M, Lipson D, Stephens PJ, Ross JS, Miller VA, Agarwal N, Shuch B, Choueiri TK, Chung JH (2018) Characterization of clinical cases of advanced papillary renal cell carcinoma via comprehensive genomic profiling. Eur Urol 73:71\u201378","journal-title":"Eur Urol"},{"key":"369_CR339","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ijc.21020","volume":"116","author":"R Palmqvist","year":"2005","unstructured":"Palmqvist R, Zhang A, Xu D, Golovleva I, Norrback KF, Gruber A, Oberg A, Stenling R, Roos G (2005) hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer. Int J Cancer 116:395\u2013400","journal-title":"Int J Cancer"},{"key":"369_CR340","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ajh.24324","volume":"91","author":"J Panero","year":"2016","unstructured":"Panero J, Alves-Paiva RM, Roisman A, Santana-Lemos BA, Falcao RP, Oliveira G, Martins D, Stanganelli C, Slavutsky I, Calado RT (2016) Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma. Am J Hematol 91:481\u2013485","journal-title":"Am J Hematol"},{"key":"369_CR341","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molcel.2019.07.010","volume":"76","author":"S Panier","year":"2019","unstructured":"Panier S, Maric M, Hewitt G, Mason-Osann E, Gali H, Dai A, Labadorf A, Guervilly JH, Ruis P, Segura-Bayona S, Belan O, Marzec P, Gaillard PL, Flynn RL, Boulton SJ (2019) SLX4IP antagonizes promiscuous BLM activity during ALT maintenance. Mol Cell 76:27\u201343.e11","journal-title":"Mol Cell"},{"key":"369_CR342","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/jclinpath-2018-205570","volume":"72","author":"F Pareja","year":"2019","unstructured":"Pareja F, Paula ADC, Murray MP, Hoang T, Gularte-M\u00e9rida R, Brown D, da Silva EM, Sebastiao APM, Giri DD, Weigelt B, Reis-Filho JS, Brogi E (2019) Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults. J Clin Pathol 72:258\u2013262","journal-title":"J Clin Pathol"},{"key":"369_CR343","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature14980","volume":"526","author":"M Peifer","year":"2015","unstructured":"Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Kramer A, Roncaioli JL, Sand F, Heuckmann JM, Ikram F, Schmidt R, Ackermann S, Engesser A, Kahlert Y, Vogel W, Altmuller J, Nurnberg P, Thierry-Mieg J, Thierry-Mieg D, Mariappan A, Heynck S, Mariotti E, Henrich KO, Gloeckner C, Bosco G, Leuschner I, Schweiger MR, Savelyeva L, Watkins SC, Shao C, Bell E, Hofer T, Achter V, Lang U, Theissen J, Volland R, Saadati M, Eggert A, de Wilde B, Berthold F, Peng Z, Zhao C, Shi L, Ortmann M, Buttner R, Perner S, Hero B, Schramm A, Schulte JH, Herrmann C, O\u2019Sullivan RJ, Westermann F, Thomas RK, Fischer M (2015) Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature 526:700\u2013704","journal-title":"Nature"},{"key":"369_CR344","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00401-017-1690-1","volume":"133","author":"M Pekmezci","year":"2017","unstructured":"Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, Bracci PM, Eckel-Passow JE, Lachance DH, Clarke J, Taylor JW, Luks T, Wiencke JK, Jenkins RB, Wrensch MR (2017) Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta Neuropathol 133:1001\u20131016","journal-title":"Acta Neuropathol"},{"key":"369_CR345","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/gutjnl-2020-323153","volume":"71","author":"C P\u00e9neau","year":"2022","unstructured":"P\u00e9neau C, Imbeaud S, La Bella T, Hirsch TZ, Caruso S, Calderaro J, Paradis V, Blanc JF, Letouz\u00e9 E, Nault JC, Amaddeo G, Zucman-Rossi J (2022) Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut 71:616\u2013626","journal-title":"Gut"},{"key":"369_CR346","doi-asserted-by":"publisher","first-page":"21755","DOI":"10.18632\/oncotarget.4580","volume":"6","author":"M Penzo","year":"2015","unstructured":"Penzo M, Ludovini V, Trere D, Siggillino A, Vannucci J, Bellezza G, Crino L, Montanaro L (2015) Dyskerin and TERC expression may condition survival in lung cancer patients. Oncotarget 6:21755\u201321760","journal-title":"Oncotarget"},{"key":"369_CR347","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1128\/MCB.21.12.3862-3875.2001","volume":"21","author":"K Perrem","year":"2001","unstructured":"Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR (2001) Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 21:3862\u20133875","journal-title":"Mol Cell Biol"},{"key":"369_CR348","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1530\/JME-16-0195","volume":"58","author":"A Pestana","year":"2017","unstructured":"Pestana A, Vinagre J, Sobrinho-Simoes M, Soares P (2017) TERT biology and function in cancer: beyond immortalisation. J Mol Endocrinol 58:R129\u2013R146","journal-title":"J Mol Endocrinol"},{"key":"369_CR349","doi-asserted-by":"publisher","first-page":"7493","DOI":"10.18632\/oncotarget.2115","volume":"6","author":"A Pezzolo","year":"2015","unstructured":"Pezzolo A, Pistorio A, Gambini C, Haupt R, Ferraro M, Erminio G, De Bernardi B, Garaventa A, Pistoia V (2015) Intratumoral diversity of telomere length in individual neuroblastoma tumors. Oncotarget 6:7493\u20137503","journal-title":"Oncotarget"},{"key":"369_CR350","doi-asserted-by":"publisher","first-page":"54253","DOI":"10.18632\/oncotarget.9801","volume":"7","author":"F Pezzuto","year":"2016","unstructured":"Pezzuto F, Izzo F, Buonaguro L, Annunziata C, Tatangelo F, Botti G, Buonaguro FM, Tornesello ML (2016) Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma. Oncotarget 7:54253\u201354262","journal-title":"Oncotarget"},{"key":"369_CR351","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.3390\/cancers13153771","volume":"13","author":"F Pezzuto","year":"2021","unstructured":"Pezzuto F, Izzo F, De Luca P, Biffali E, Buonaguro L, Tatangelo F, Buonaguro FM, Tornesello ML (2021) Clinical significance of telomerase reverse-transcriptase promoter mutations in hepatocellular carcinoma. Cancers (Basel) 13:3771","journal-title":"Cancers (Basel)"},{"key":"369_CR352","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/bpa.12639","volume":"29","author":"JJ Phillips","year":"2019","unstructured":"Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Bastian BC, Grenert JP, Kline CN, Mueller S, Banerjee A, Nicolaides T, Gupta N, Berger MS, Lee HS, Pekmezci M, Tihan T, Bollen AW, Perry A, Shieh JTC, Solomon DA (2019) The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. Brain Pathol 29:85\u201396","journal-title":"Brain Pathol"},{"key":"369_CR353","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","volume":"72","author":"EJ Pietzak","year":"2017","unstructured":"Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, Zehir A, Schultz N, Rosenberg JE, Bajorin DF, Dalbagni G, Al-Ahmadie H, Solit DB, Bochner BH (2017) Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets. Eur Urol 72:952\u2013959","journal-title":"Eur Urol"},{"key":"369_CR354","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccr.2014.03.005","volume":"25","author":"C Pilati","year":"2014","unstructured":"Pilati C, Letouze E, Nault JC, Imbeaud S, Boulai A, Calderaro J, Poussin K, Franconi A, Couchy G, Morcrette G, Mallet M, Taouji S, Balabaud C, Terris B, Canal F, Paradis V, Scoazec JY, de Muret A, Guettier C, Bioulac-Sage P, Chevet E, Calvo F, Zucman-Rossi J (2014) Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell 25:428\u2013441","journal-title":"Cancer Cell"},{"key":"369_CR355","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41379-018-0007-9","volume":"31","author":"JA Pilsworth","year":"2018","unstructured":"Pilsworth JA, Cochrane DR, Xia Z, Aubert G, F\u00e4rkkil\u00e4 AEM, Horlings HM, Yanagida S, Yang W, Lim JLP, Wang YK, Bashashati A, Keul J, Wong A, Norris K, Brucker SY, Taran FA, Kr\u00e4mer B, Staebler A, van Meurs H, Oliva E, Shah SP, Kommoss S, Kommoss F, Gilks CB, Baird DM, Huntsman DG (2018) TERT promoter mutation in adult granulosa cell tumor of the ovary. Mod Pathol 31:1107\u20131115","journal-title":"Mod Pathol"},{"key":"369_CR356","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jhep.2014.05.028","volume":"61","author":"R Pinyol","year":"2014","unstructured":"Pinyol R, Tovar V, Llovet JM (2014) TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma. J Hepatol 61:685\u2013687","journal-title":"J Hepatol"},{"key":"369_CR357","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1158\/1078-0432.CCR-19-3573","volume":"26","author":"C Pirker","year":"2020","unstructured":"Pirker C, Bilecz A, Grusch M, Mohr T, Heidenreich B, Laszlo V, Stockhammer P, L\u00f6tsch-Gojo D, Gojo J, Gabler L, Spiegl-Kreinecker S, Dome B, Steindl A, Klikovits T, Hoda MA, Jakopovic M, Samarzija M, Mohorcic K, Kern I, Kiesel B, Brcic L, Oberndorfer F, M\u00fcllauer L, Klepetko W, Schmidt WM, Kumar R, Hegedus B, Berger W (2020) Telomerase reverse transcriptase promoter mutations identify a Genomically defined and highly aggressive human pleural mesothelioma subgroup. Clin Cancer Res 26:3819\u20133830","journal-title":"Clin Cancer Res"},{"key":"369_CR358","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/path.4672","volume":"238","author":"S Piscuoglio","year":"2016","unstructured":"Piscuoglio S, Ng CK, Murray M, Burke KA, Edelweiss M, Geyer FC, Macedo GS, Inagaki A, Papanastasiou AD, Martelotto LG, Marchio C, Lim RS, Ioris RA, Nahar PK, Bruijn ID, Smyth L, Akram M, Ross D, Petrini JH, Norton L, Solit DB, Baselga J, Brogi E, Ladanyi M, Weigelt B, Reis-Filho JS (2016) Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression. J Pathol 238:508\u2013518","journal-title":"J Pathol"},{"key":"369_CR359","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mrfmmm.2011.11.002","volume":"730","author":"JD Podlevsky","year":"2012","unstructured":"Podlevsky JD, Chen JJ (2012) It all comes together at the ends: telomerase structure, function, and biogenesis. Mutat Res 730:3\u201311","journal-title":"Mutat Res"},{"key":"369_CR360","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/jid.2014.163","volume":"134","author":"H Populo","year":"2014","unstructured":"Populo H, Boaventura P, Vinagre J, Batista R, Mendes A, Caldas R, Pardal J, Azevedo F, Honavar M, Guimaraes I, Manuel Lopes J, Sobrinho-Simoes M, Soares P (2014) TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation. J Invest Dermatol 134:2251\u20132257","journal-title":"J Invest Dermatol"},{"key":"369_CR361","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/cancers12061625","volume":"12","author":"A Posch","year":"2020","unstructured":"Posch A, Hofer-Zeni S, Klieser E, Primavesi F, Naderlinger E, Brandstetter A, Filipits M, Urbas R, Swiercynski S, J\u00e4ger T, Winkelmann P, Kiesslich T, Lu L, Neureiter D, St\u00e4ttner S, Holzmann K (2020) Hot spot TERT promoter mutations are rare in sporadic pancreatic neuroendocrine neoplasms and associated with telomere length and epigenetic expression patterns. Cancers (Basel) 12:1625","journal-title":"Cancers (Basel)"},{"key":"369_CR362","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.euf.2017.03.007","volume":"4","author":"DS Priemer","year":"2017","unstructured":"Priemer DS, Wang M, Zhang S, Lopez-Beltran A, Kouba E, Montironi R, Davidson DD, MacLennan GT, Wang L, Osunkoya AO, Deng Y, Emerson RE, Cheng L (2017) Small-cell carcinomas of the urinary bladder and prostate: TERT promoter mutation status differentiates sites of malignancy and provides evidence of common clonality between small-cell carcinoma of the urinary bladder and urothelial carcinoma. Eur Urol Focus 4:880","journal-title":"Eur Urol Focus"},{"key":"369_CR363","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/exd.12080","volume":"22","author":"JA Puig-Butille","year":"2013","unstructured":"Puig-Butille JA, Badenas C, Ogbah Z, Carrera C, Aguilera P, Malvehy J, Puig S (2013) Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma. Exp Dermatol 22:148\u2013150","journal-title":"Exp Dermatol"},{"key":"369_CR364","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1530\/ERC-15-0396","volume":"22","author":"E Qasem","year":"2015","unstructured":"Qasem E, Murugan AK, Al-Hindi H, Xing M, Almohanna M, Alswailem M, Alzahrani AS (2015) TERT promoter mutations in thyroid cancer: a report from a middle eastern population. Endocr Relat Cancer 22:901\u2013908","journal-title":"Endocr Relat Cancer"},{"key":"369_CR365","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ijc.28728","volume":"135","author":"Y Qu","year":"2014","unstructured":"Qu Y, Dang S, Wu K, Shao Y, Yang Q, Ji M, Shi B, Hou P (2014a) TERT promoter mutations predict worse survival in laryngeal cancer patients. Int J Cancer 135:1008\u20131010","journal-title":"Int J Cancer"},{"key":"369_CR366","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/ijc.28633","volume":"134","author":"Y Qu","year":"2014","unstructured":"Qu Y, Shi L, Wang D, Zhang B, Yang Q, Ji M, Shi B, Hou P (2014b) Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers. Int J Cancer 134:2993\u20132994","journal-title":"Int J Cancer"},{"key":"369_CR367","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00428-014-1658-7","volume":"465","author":"A Quaas","year":"2014","unstructured":"Quaas A, Oldopp T, Tharun L, Klingenfeld C, Krech T, Sauter G, Grob TJ (2014) Frequency of TERT promoter mutations in primary tumors of the liver. Virchows Arch 465:673\u2013677","journal-title":"Virchows Arch"},{"key":"369_CR368","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/1878-0261.12651","volume":"14","author":"L Quetel","year":"2020","unstructured":"Quetel L, Meiller C, Assi\u00e9 JB, Blum Y, Imbeaud S, Montagne F, Tranchant R, de Wolf J, Caruso S, Copin MC, Hofman V, Gibault L, Badoual C, Pintilie E, Hofman P, Monnet I, Scherpereel A, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D (2020) Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival. Mol Oncol 14:1207\u20131223","journal-title":"Mol Oncol"},{"key":"369_CR369","doi-asserted-by":"publisher","first-page":"17426","DOI":"10.1073\/pnas.1310522110","volume":"110","author":"PS Rachakonda","year":"2013","unstructured":"Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C, Wiklund NP, Steineck G, Schadendorf D, Hemminki K, Kumar R (2013) TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci USA 110:17426\u201317431","journal-title":"Proc Natl Acad Sci USA"},{"key":"369_CR370","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1165","volume":"3","author":"H Rajagopalan","year":"2003","unstructured":"Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C (2003) The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3:695\u2013701","journal-title":"Nat Rev Cancer"},{"key":"369_CR371","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1038\/s41379-020-0565-5","volume":"33","author":"NS Ramani","year":"2020","unstructured":"Ramani NS, Aung PP, Gu J, Sfamenos S, Sdringola-Maranga C, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Diab A, Prieto VG, Hwu WJ, Torres-Cabala CA (2020) TERT amplification but not activation of canonical Wnt\/\u03b2-catenin pathway is involved in acral lentiginous melanoma progression to metastasis. Mod Pathol 33:2067\u20132074","journal-title":"Mod Pathol"},{"key":"369_CR372","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1093\/nar\/gkq296","volume":"38","author":"S Redon","year":"2010","unstructured":"Redon S, Reichenbach P, Lingner J (2010) The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res 38:5797\u20135806","journal-title":"Nucleic Acids Res"},{"key":"369_CR373","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00401-013-1198-2","volume":"126","author":"M Remke","year":"2013","unstructured":"Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, Luu B, Jones DT, Garzia L, Dubuc AM, Zhukova N, Vanner R, Kros JM, French PJ, Van Meir EG, Vibhakar R, Zitterbart K, Chan JA, Bognar L, Klekner A, Lach B, Jung S, Saad AG, Liau LM, Albrecht S, Zollo M, Cooper MK, Thompson RC, Delattre OO, Bourdeaut F, Doz FF, Garami M, Hauser P, Carlotti CG, Van Meter TE, Massimi L, Fults D, Pomeroy SL, Kumabe T, Ra YS, Leonard JR, Elbabaa SK, Mora J, Rubin JB, Cho YJ, McLendon RE, Bigner DD, Eberhart CG, Fouladi M, Wechsler-Reya RJ, Faria CC, Croul SE, Huang A, Bouffet E, Hawkins CE, Dirks PB, Weiss WA, Schuller U, Pollack IF, Rutkowski S, Meyronet D, Jouvet A, Fevre-Montange M, Jabado N, Perek-Polnik M, Grajkowska WA, Kim SK, Rutka JT, Malkin D, Tabori U, Pfister SM, Korshunov A, von Deimling A, Taylor MD (2013) TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 126:917\u2013929","journal-title":"Acta Neuropathol"},{"key":"369_CR374","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/nar\/gkl1125","volume":"35","author":"S Renaud","year":"2007","unstructured":"Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT, Lobanenkov V, Benhattar J (2007) Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 35:1245\u20131256","journal-title":"Nucleic Acids Res"},{"key":"369_CR375","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ccr.2012.03.001","volume":"21","author":"E Rheinbay","year":"2012","unstructured":"Rheinbay E, Louis DN, Bernstein BE, Suva ML (2012) A tell-tail sign of chromatin: histone mutations drive pediatric glioblastoma. Cancer Cell 21:329\u2013331","journal-title":"Cancer Cell"},{"key":"369_CR376","first-page":"1801","volume":"54","author":"T Ried","year":"1994","unstructured":"Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schr\u00f6ck E, du Manoir S, Cremer T (1994) Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54:1801\u20131806","journal-title":"Cancer Res"},{"key":"369_CR377","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nsmb.3078","volume":"22","author":"K Rippe","year":"2015","unstructured":"Rippe K, Luke B (2015) TERRA and the state of the telomere. Nat Struct Mol Biol 22:853\u2013858","journal-title":"Nat Struct Mol Biol"},{"key":"369_CR378","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1101\/gad.251041.114","volume":"28","author":"JD Robin","year":"2014","unstructured":"Robin JD, Ludlow AT, Batten K, Magdinier F, Stadler G, Wagner KR, Shay JW, Wright WE (2014) Telomere position effect: regulation of gene expression with progressive telomere shortening over long distances. Genes Dev 28:2464\u20132476","journal-title":"Genes Dev"},{"key":"369_CR379","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00428-017-2164-5","volume":"471","author":"MDC Rodriguez Pena","year":"2017","unstructured":"Rodriguez Pena MDC, Tregnago AC, Eich ML, Springer S, Wang Y, Taheri D, Ertoy D, Fujita K, Bezerra SM, Cunha IW, Raspollini MR, Yu L, Bivalacqua TJ, Papadopoulos N, Kinzler KW, Vogelstein B, Netto GJ (2017) Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder. Virchows Arch 471:761\u2013767","journal-title":"Virchows Arch"},{"key":"369_CR380","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00401-016-1619-0","volume":"132","author":"FJ Rodriguez","year":"2016","unstructured":"Rodriguez FJ, Vizcaino MA, Blakeley J, Heaphy CM (2016) Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas. Acta Neuropathol 132:761\u2013763","journal-title":"Acta Neuropathol"},{"key":"369_CR381","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/bpa.12646","volume":"29","author":"FJ Rodriguez","year":"2019","unstructured":"Rodriguez FJ, Brosnan-Cashman JA, Allen SJ, Vizcaino MA, Giannini C, Camelo-Piragua S, Webb M, Matsushita M, Wadhwani N, Tabbarah A, Hamideh D, Jiang L, Chen L, Arvanitis LD, Alnajar HH, Barber JR, Rodr\u00edguez-Velasco A, Orr B, Heaphy CM (2019a) Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia. Brain Pathol 29:126\u2013140","journal-title":"Brain Pathol"},{"key":"369_CR382","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40478-019-0792-5","volume":"7","author":"FJ Rodriguez","year":"2019","unstructured":"Rodriguez FJ, Graham MK, Brosnan-Cashman JA, Barber JR, Davis C, Vizcaino MA, Palsgrove DN, Giannini C, Pekmezci M, Dahiya S, Gokden M, No\u00eb M, Wood LD, Pratilas CA, Morris CD, Belzberg A, Blakeley J, Heaphy CM (2019b) Telomere alterations in neurofibromatosis type 1-associated solid tumors. Acta Neuropathol Commun 7:139","journal-title":"Acta Neuropathol Commun"},{"key":"369_CR383","doi-asserted-by":"publisher","first-page":"77.e17","DOI":"10.1016\/j.urolonc.2019.08.007","volume":"38","author":"J Roggisch","year":"2020","unstructured":"Roggisch J, Ecke T, Koch S (2020) Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer. Urol Oncol 38:77.e17\u201377.e25","journal-title":"Urol Oncol"},{"key":"369_CR384","first-page":"134","volume":"7","author":"MR Roh","year":"2017","unstructured":"Roh MR, Park KH, Chung KY, Shin SJ, Rha SY, Tsao H (2017) Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients. Am J Cancer Res 7:134\u2013138","journal-title":"Am J Cancer Res"},{"key":"369_CR385","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/sj.bjc.6690433","volume":"80","author":"PH Rooney","year":"1999","unstructured":"Rooney PH, Murray GI, Stevenson DA, Haites NE, Cassidy J, McLeod HL (1999) Comparative genomic hybridization and chromosomal instability in solid tumours. Br J Cancer 80:862\u2013873","journal-title":"Br J Cancer"},{"key":"369_CR386","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv377","volume":"108","author":"F Sahm","year":"2016","unstructured":"Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T, Wang Q, Sulman EP, Adeberg S, Koch A, Okuducu AF, Brehmer S, Schittenhelm J, Becker A, Brokinkel B, Schmidt M, Ull T, Gousias K, Kessler AF, Lamszus K, Debus J, Mawrin C, Kim YJ, Simon M, Ketter R, Paulus W, Aldape KD, Herold-Mende C, von Deimling A (2016) TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst 108:djv377","journal-title":"J Natl Cancer Inst"},{"key":"369_CR387","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3892\/mco.2015.674","volume":"4","author":"T Saito","year":"2016","unstructured":"Saito T, Akaike K, Kurisaki-Arakawa A, Toda-Ishii M, Mukaihara K, Suehara Y, Takagi T, Kaneko K, Yao T (2016) TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients. Mol Clin Oncol 4:61\u201364","journal-title":"Mol Clin Oncol"},{"key":"369_CR388","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13059-020-02035-x","volume":"21","author":"S Sakthikumar","year":"2020","unstructured":"Sakthikumar S, Roy A, Haseeb L, Pettersson ME, Sundstr\u00f6m E, Marinescu VD, Lindblad-Toh K, Forsberg-Nilsson K (2020) Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes. Genome Biol 21:127","journal-title":"Genome Biol"},{"key":"369_CR389","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.11202","volume":"5","author":"S Sampl","year":"2012","unstructured":"Sampl S, Pramhas S, Stern C, Preusser M, Marosi C, Holzmann K (2012) Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade. Transl Oncol 5:56-IN54","journal-title":"Transl Oncol"},{"key":"369_CR390","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1200\/JCO.2004.03.043","volume":"22","author":"RP Sanders","year":"2004","unstructured":"Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, Dome JS (2004) Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol 22:3790\u20133797","journal-title":"J Clin Oncol"},{"key":"369_CR391","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrc2771","volume":"10","author":"T Santarius","year":"2010","unstructured":"Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS (2010) A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 10:59\u201364","journal-title":"Nat Rev Cancer"},{"key":"369_CR392","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Davi MV, Landoni L, Malpaga A, Miotto M, Whitehall VL, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LM, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M et al (2017) Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543:65\u201371","journal-title":"Nature"},{"key":"369_CR393","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00428-002-0634-9","volume":"440","author":"C Scheel","year":"2002","unstructured":"Scheel C, Poremba C (2002) Telomere lengthening in telomerase-negative cells: the ends are coming together. Virchows Arch 440:573\u2013582","journal-title":"Virchows Arch"},{"key":"369_CR394","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1101\/gad.263863.115","volume":"29","author":"JC Schmidt","year":"2015","unstructured":"Schmidt JC, Cech TR (2015) Human telomerase: biogenesis, trafficking, recruitment, and activation. Genes Dev 29:1095\u20131105","journal-title":"Genes Dev"},{"key":"369_CR395","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb1685","volume":"10","author":"S Schoeftner","year":"2008","unstructured":"Schoeftner S, Blasco MA (2008) Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 10:228\u2013236","journal-title":"Nat Cell Biol"},{"key":"369_CR396","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1167\/iovs.15-17469","volume":"56","author":"SL Scholz","year":"2015","unstructured":"Scholz SL, Thomasen H, Reis H, Moller I, Darawsha R, Muller B, Dekowski D, Sucker A, Schilling B, Schadendorf D, Steuhl KP, Paschen A, Westekemper H, Meller D, Griewank KG (2015) Frequent TERT promoter mutations in ocular surface squamous neoplasia. Invest Ophthalmol Vis Sci 56:5854\u20135861","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"369_CR397","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, Calatayud AL, Pinyol R, Pelletier L, Balabaud C, Laurent A, Blanc JF, Mazzaferro V, Calvo F, Villanueva A, Nault JC, Bioulac-Sage P, Stratton MR, Llovet JM, Zucman-Rossi J (2015) Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 47:505\u2013511","journal-title":"Nat Genet"},{"key":"369_CR398","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jager N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Fruhwald MC, Roggendorf W, Kramm C, Durken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, Jabado N (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226\u2013231","journal-title":"Nature"},{"key":"369_CR399","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/modpathol.2013.167","volume":"27","author":"GA Scott","year":"2014","unstructured":"Scott GA, Laughlin TS, Rothberg PG (2014) Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma. Mod Pathol 27:516\u2013523","journal-title":"Mod Pathol"},{"key":"369_CR400","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.1218498","volume":"336","author":"A Sfeir","year":"2012","unstructured":"Sfeir A, de Lange T (2012) Removal of shelterin reveals the telomere end-protection problem. Science 336:593\u2013597","journal-title":"Science"},{"key":"369_CR401","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ng.3382","volume":"47","author":"AH Shain","year":"2015","unstructured":"Shain AH, Garrido M, Botton T, Talevich E, Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, Thompson JF, Wiesner T, Roy R, Olshen AB, Gagnon A, Gray JW, Huh N, Hur JS, Busam KJ, Scolyer RA, Cho RJ, Murali R, Bastian BC (2015) Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet 47:1194\u20131199","journal-title":"Nat Genet"},{"key":"369_CR402","doi-asserted-by":"publisher","first-page":"E632","DOI":"10.1210\/jc.2014-3606","volume":"100","author":"X Shi","year":"2015","unstructured":"Shi X, Liu R, Qu S, Zhu G, Bishop J, Liu X, Sun H, Shan Z, Wang E, Luo Y, Yang X, Zhao J, Du J, El-Naggar AK, Teng W, Xing M (2015) Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer. J Clin Endocrinol Metab 100:E632\u2013E637","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR403","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1002\/cam4.1666","volume":"7","author":"C Shu","year":"2018","unstructured":"Shu C, Wang Q, Yan X, Wang J (2018) The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival. Cancer Med 7:3704\u20133712","journal-title":"Cancer Med"},{"key":"369_CR404","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/neuonc\/nou158","volume":"17","author":"M Simon","year":"2015","unstructured":"Simon M, Hosen I, Gousias K, Rachakonda S, Heidenreich B, Gessi M, Schramm J, Hemminki K, Waha A, Kumar R (2015) TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas. Neuro-Oncol 17:45\u201352","journal-title":"Neuro-Oncol"},{"key":"369_CR405","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/1078-0432.CCR-16-1113","volume":"23","author":"AD Singhi","year":"2017","unstructured":"Singhi AD, Liu TC, Roncaioli JL, Cao D, Zeh HJ, Zureikat AH, Tsung A, Marsh JW, Lee KK, Hogg ME, Bahary N, Brand RE, McGrath KM, Slivka A, Cressman KL, Fuhrer K, O\u2019Sullivan RJ (2017) Alternative lengthening of telomeres and loss of DAXX\/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumors. Clin Cancer Res 23:600\u2013609","journal-title":"Clin Cancer Res"},{"key":"369_CR406","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.ygeno.2019.09.017","volume":"112","author":"AK Siraj","year":"2020","unstructured":"Siraj AK, Bu R, Iqbal K, Parvathareddy SK, Siraj N, Siraj S, Diaz MRF, Rala DR, Benito AD, Sabido MA, Al-Rasheed M, Al-Obaisi KAS, Al-Haqawi W, Victoria IG, Al Balawy W, Abedalthagafi M, Wakil SM, Ajarim D, Mohammed S, Alhussain T, Tulbah A, Al-Badawi IA, Al-Dayel F, Al-Kuraya KS (2020) Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population. Genomics 112:1746\u20131753","journal-title":"Genomics"},{"key":"369_CR407","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/path.2981","volume":"226","author":"TL Slatter","year":"2012","unstructured":"Slatter TL, Tan X, Yuen YC, Gunningham S, Ma SS, Daly E, Packer S, Devenish C, Royds JA, Hung NA (2012) The alternative lengthening of telomeres pathway may operate in non-neoplastic human cells. J Pathol 226:509\u2013518","journal-title":"J Pathol"},{"key":"369_CR408","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.onc.1201066","volume":"14","author":"AI Soder","year":"1997","unstructured":"Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN (1997) Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14:1013\u20131021","journal-title":"Oncogene"},{"key":"369_CR409","first-page":"1010","volume":"55","author":"MR Speicher","year":"1995","unstructured":"Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55:1010\u20131013","journal-title":"Cancer Res"},{"key":"369_CR410","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/nov010","volume":"17","author":"S Spiegl-Kreinecker","year":"2015","unstructured":"Spiegl-Kreinecker S, Lotsch D, Ghanim B, Pirker C, Mohr T, Laaber M, Weis S, Olschowski A, Webersinke G, Pichler J, Berger W (2015) Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis. Neuro-Oncology 17:1231\u20131240","journal-title":"Neuro-Oncology"},{"key":"369_CR411","first-page":"2067","volume":"60","author":"GS Stein","year":"2000","unstructured":"Stein GS, Montecino M, van Wijnen AJ, Stein JL, Lian JB (2000) Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer. Cancer Res 60:2067\u20132076","journal-title":"Cancer Res"},{"key":"369_CR412","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458:719","journal-title":"Nature"},{"key":"369_CR413","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/modpathol.2009.125","volume":"22","author":"AP Subhawong","year":"2009","unstructured":"Subhawong AP, Heaphy CM, Argani P, Konishi Y, Kouprina N, Nassar H, Vang R, Meeker AK (2009) The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression. Mod Pathol 22:1423\u20131431","journal-title":"Mod Pathol"},{"key":"369_CR414","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0165-4608(99)00135-1","volume":"117","author":"M Sugita","year":"2000","unstructured":"Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, West J, Drabkin HA, Gemmill RM (2000) Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet 117:9\u201318","journal-title":"Cancer Genet Cytogenet"},{"key":"369_CR415","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153319","volume":"11","author":"J Sun","year":"2016","unstructured":"Sun J, Zhang J, Lu J, Gao J, Ren X, Teng L, Duan H, Lin Y, Li X, Zhang B, Liang Z (2016) BRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in Chinese patients. PLoS One 11:e0153319","journal-title":"PLoS One"},{"key":"369_CR416","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.bcp.2004.04.030","volume":"68","author":"M Szyf","year":"2004","unstructured":"Szyf M, Pakneshan P, Rabbani SA (2004) DNA methylation and breast cancer. Biochem Pharmacol 68:1187\u20131197","journal-title":"Biochem Pharmacol"},{"key":"369_CR417","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1440-1746.2004.03447.x","volume":"19","author":"Y Takuma","year":"2004","unstructured":"Takuma Y, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Matsumoto E, Fujikawa T, Suzuki M, Hanafusa T, Shiratori Y (2004) Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. J Gastroenterol Hepatol 19:1300\u20131304","journal-title":"J Gastroenterol Hepatol"},{"key":"369_CR418","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1038\/onc.2013.351","volume":"33","author":"A Tallet","year":"2014","unstructured":"Tallet A, Nault JC, Renier A, Hysi I, Galateau-Salle F, Cazes A, Copin MC, Hofman P, Andujar P, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D (2014) Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma. Oncogene 33:3748\u20133752","journal-title":"Oncogene"},{"key":"369_CR419","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1089\/thy.2018.0695","volume":"29","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Matsuse M, Saenko V, Nakao T, Yamanouchi K, Sakimura C, Yano H, Nishihara E, Hirokawa M, Suzuki K, Miyauchi A, Eguchi S, Yoshiura KI, Yamashita S, Nagayasu T, Mitsutake N (2019) TERT mRNA expression as a novel prognostic marker in papillary thyroid carcinomas. Thyroid 29:1105\u20131114","journal-title":"Thyroid"},{"key":"369_CR420","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<114::AID-IJC4>3.0.CO;2-Q","volume":"84","author":"M Tarkkanen","year":"1999","unstructured":"Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, Kellokumpu-Lehtinen P, Bohling T, Valle J, Knuutila S (1999) DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84:114\u2013121","journal-title":"Int J Cancer"},{"key":"369_CR421","first-page":"90","volume":"38","author":"NK Terzi","year":"2022","unstructured":"Terzi NK, Yilmaz I, Oz AB (2022) The place and prognostic value of TERT promoter mutation in molecular classification in grade II-III glial tumors and primary glioblastomas. Turk Patoloji Derg 38:90\u201398","journal-title":"Turk Patoloji Derg"},{"key":"369_CR422","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ng.3126","volume":"46","author":"Y Totoki","year":"2014","unstructured":"Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, Yamamoto S, Shinbrot E, Hama N, Lehmkuhl M, Hosoda F, Arai Y, Walker K, Dahdouli M, Gotoh K, Nagae G, Gingras MC, Muzny DM, Ojima H, Shimada K, Midorikawa Y, Goss JA, Cotton R, Hayashi A, Shibahara J, Ishikawa S, Guiteau J, Tanaka M, Urushidate T, Ohashi S, Okada N, Doddapaneni H, Wang M, Zhu Y, Dinh H, Okusaka T, Kokudo N, Kosuge T, Takayama T, Fukayama M, Gibbs RA, Wheeler DA, Aburatani H, Shibata T (2014) Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet 46:1267\u20131273","journal-title":"Nat Genet"},{"key":"369_CR423","first-page":"1887","volume":"23","author":"J Trifunovic","year":"2018","unstructured":"Trifunovic J, Basta Jovanovic G, Nikolic N, Carkic J, Marjanovic A, Brankovic M, Radojevic Skodric S, Prvanovic M, Jovanovic A, Dzamic Z, Milasin J (2018) HTERT promoter methylation and single nucleotide polymorphism (\u2212245 T>C) affect renal cell carcinoma behavior in Serbian population. J BUON 23:1887\u20131892","journal-title":"J BUON"},{"key":"369_CR424","first-page":"1759","volume":"63","author":"GA Ulaner","year":"2003","unstructured":"Ulaner GA, Huang HY, Otero J, Zhao ZQ, Ben-Porat L, Satagopan JM, Gorlick R, Meyers P, Healey JH, Huvos AG, Hoffman AR, Ladanyi M (2003) Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res 63:1759\u20131763","journal-title":"Cancer Res"},{"key":"369_CR425","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/gcc.20074","volume":"41","author":"GA Ulaner","year":"2004","unstructured":"Ulaner GA, Hoffman AR, Otero J, Huang HY, Zhao Z, Mazumdar M, Gorlick R, Meyers P, Healey JH, Ladanyi M (2004) Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing\u2019s sarcomas and osteosarcomas. Genes Chromosomes Cancer 41:155\u2013162","journal-title":"Genes Chromosomes Cancer"},{"key":"369_CR426","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.anndiagpath.2015.06.007","volume":"19","author":"E Vail","year":"2015","unstructured":"Vail E, Zheng X, Zhou M, Yang X, Fallon JT, Epstein JI, Zhong M (2015) Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder. Ann Diagn Pathol 19:301\u2013305","journal-title":"Ann Diagn Pathol"},{"key":"369_CR427","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3892\/ol.2011.386","volume":"2","author":"C Valls-Bautista","year":"2011","unstructured":"Valls-Bautista C, Bougel S, Pinol-Felis C, Vinas-Salas J, Benhattar J (2011) hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells. Oncol Lett 2:1257\u20131260","journal-title":"Oncol Lett"},{"key":"369_CR428","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-17-2719","volume":"24","author":"KEM van Kessel","year":"2018","unstructured":"van Kessel KEM, van der Keur KA, Dyrskj\u00f8t L, Algaba F, Welvaart NYC, Beukers W, Segersten U, Keck B, Maurer T, Simic T, Horstmann M, Grimm MO, Hermann GG, Mogensen K, Hartmann A, Harving N, Petersen AC, Jensen JB, Junker K, Boormans JL, Real FX, Malats N, Malmstr\u00f6m PU, \u00d8rntoft TF, Zwarthoff EC (2018) Molecular markers increase precision of the European Association of Urology non-muscle-invasive bladder cancer progression risk groups. Clin Cancer Res 24:1586\u20131593","journal-title":"Clin Cancer Res"},{"key":"369_CR429","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/ijc.28527","volume":"134","author":"AM van Nistelrooij","year":"2014","unstructured":"van Nistelrooij AM, Zwarthoff EC, Post E, Lurkin I, van Marion R, Korpershoek E, Biermann K, Wijnhoven BP, Dinjens WN (2014) Absence of TERT promoter mutations in esophageal adenocarcinoma. Int J Cancer 134:2014\u20132015","journal-title":"Int J Cancer"},{"key":"369_CR430","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/cncy.21857","volume":"125","author":"CJ VandenBussche","year":"2017","unstructured":"VandenBussche CJ, Allison DB, Graham MK, Charu V, Lennon AM, Wolfgang CL, Hruban RH, Heaphy CM (2017) Alternative lengthening of telomeres and ATRX\/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors. Cancer Cytopathol 125:544\u2013551","journal-title":"Cancer Cytopathol"},{"key":"369_CR431","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/CMR.0000000000000222","volume":"26","author":"L Vazquez Vde","year":"2016","unstructured":"Vazquez Vde L, Vicente AL, Carloni A, Berardinelli G, Soares P, Scapulatempo C, Martinho O, Reis RM (2016) Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas. Melanoma Res 26:93\u201399","journal-title":"Melanoma Res"},{"key":"369_CR432","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/1471-2407-10-254","volume":"10","author":"L Venturini","year":"2010","unstructured":"Venturini L, Motta R, Gronchi A, Daidone M, Zaffaroni N (2010) Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis. BMC Cancer 10:254","journal-title":"BMC Cancer"},{"key":"369_CR433","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/gcc.20903","volume":"50","author":"L Venturini","year":"2011","unstructured":"Venturini L, Daidone MG, Motta R, Collini P, Spreafico F, Terenziani M, Piva L, Radice P, Perotti D, Zaffaroni N (2011) Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism. Genes Chromosomes Cancer 50:823\u2013829","journal-title":"Genes Chromosomes Cancer"},{"key":"369_CR434","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/neuonc\/nos083","volume":"14","author":"L Venturini","year":"2012","unstructured":"Venturini L, Daidone MG, Motta R, Cimino-Reale G, Hoare SF, Gronchi A, Folini M, Keith WN, Zaffaroni N (2012) Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance. Neuro-Oncology 14:736\u2013744","journal-title":"Neuro-Oncology"},{"key":"369_CR435","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000448922","volume":"84","author":"M Viana-Pereira","year":"2017","unstructured":"Viana-Pereira M, Almeida GC, Stavale JN, Malheiro S, Clara C, Lobo P, Pimentel J, Reis RM (2017) Study of hTERT and histone 3 mutations in Medulloblastoma. Pathobiology 84:108\u2013113","journal-title":"Pathobiology"},{"key":"369_CR436","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1038\/s41598-021-86611-6","volume":"11","author":"F Vianello","year":"2021","unstructured":"Vianello F, Censi S, Watutantrige-Fernando S, Barollo S, Zhu YH, Albiger N, Bertazza L, Manso J, Carducci S, Benna C, Iacobone M, Galuppini F, Pennelli G, Mian C (2021) The role of the size in thyroid cancer risk stratification. Sci Rep 11:7303","journal-title":"Sci Rep"},{"key":"369_CR437","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1158\/1078-0432.CCR-08-0099","volume":"14","author":"R Villa","year":"2008","unstructured":"Villa R, Daidone MG, Motta R, Venturini L, De Marco C, Vannelli A, Kusamura S, Baratti D, Deraco M, Costa A, Reddel RR, Zaffaroni N (2008) Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clin Cancer Res 14:4134\u20134140","journal-title":"Clin Cancer Res"},{"key":"369_CR438","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1038\/ncomms3185","volume":"4","author":"J Vinagre","year":"2013","unstructured":"Vinagre J, Almeida A, Populo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simoes M, Lima J, Maximo V, Soares P (2013) Frequency of TERT promoter mutations in human cancers. Nat Commun 4:2185","journal-title":"Nat Commun"},{"key":"369_CR439","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00428-014-1608-4","volume":"465","author":"J Vinagre","year":"2014","unstructured":"Vinagre J, Pinto V, Celestino R, Reis M, Populo H, Boaventura P, Melo M, Catarino T, Lima J, Lopes JM, Maximo V, Sobrinho-Simoes M, Soares P (2014) Telomerase promoter mutations in cancer: an emerging molecular biomarker? Virchows Arch 465:119\u2013133","journal-title":"Virchows Arch"},{"key":"369_CR440","doi-asserted-by":"publisher","first-page":"29714","DOI":"10.1038\/srep29714","volume":"6","author":"J Vinagre","year":"2016","unstructured":"Vinagre J, Nabais J, Pinheiro J, Batista R, Oliveira RC, Goncalves AP, Pestana A, Reis M, Mesquita B, Pinto V, Lyra J, Cipriano MA, Ferreira MG, Lopes JM, Sobrinho-Simoes M, Soares P (2016) TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes. Sci Rep 6:29714","journal-title":"Sci Rep"},{"key":"369_CR441","doi-asserted-by":"publisher","first-page":"7907","DOI":"10.1007\/s13277-015-4694-2","volume":"37","author":"V Vinothkumar","year":"2016","unstructured":"Vinothkumar V, Arunkumar G, Revathidevi S, Arun K, Manikandan M, Kuha A, Rao M, Rajkumar KS, Ajay C, Rajaraman R (2016) TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas. Tumour Biol 37:7907","journal-title":"Tumour Biol"},{"key":"369_CR442","first-page":"518","volume":"35","author":"J Visnovsky","year":"2014","unstructured":"Visnovsky J, Kudela E, Farkasova A, Balharek T, Krkoska M, Danko J (2014) Amplification of TERT and TERC genes in cervical intraepithelial neoplasia and cervical cancer. Neuro Endocrinol Lett 35:518\u2013522","journal-title":"Neuro Endocrinol Lett"},{"key":"369_CR443","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.18632\/oncotarget.1829","volume":"5","author":"K Wang","year":"2014","unstructured":"Wang K, Liu T, Liu L, Liu J, Liu C, Wang C, Ge N, Ren H, Yan K, Hu S, Bjorkholm M, Fan Y, Xu D (2014b) TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas. Oncotarget 5:1829\u20131836","journal-title":"Oncotarget"},{"key":"369_CR444","doi-asserted-by":"publisher","first-page":"12428","DOI":"10.18632\/oncotarget.2660","volume":"5","author":"K Wang","year":"2014","unstructured":"Wang K, Liu TT, Ge N, Liu L, Yuan XT, Liu JK, Kong F, Wang C, Ren HB, Yan KQ, Hu SY, Xu ZH, Bjrkholm M, Fan YD, Zhao ST, Liu C, Xu DW (2014c) TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR. Oncotarget 5:12428\u201312439","journal-title":"Oncotarget"},{"key":"369_CR445","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1002\/cncr.28800","volume":"120","author":"N Wang","year":"2014","unstructured":"Wang N, Liu TT, Sofiadis A, Juhlin CC, Zedenius J, Hoog A, Larsson C, Xu DW (2014d) TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. Cancer 120:2965\u20132979","journal-title":"Cancer"},{"key":"369_CR446","doi-asserted-by":"publisher","first-page":"E1571","DOI":"10.1210\/jc.2014-1158","volume":"99","author":"N Wang","year":"2014","unstructured":"Wang N, Xu D, Sofiadis A, Hoog A, Vukojevic V, Backdahl M, Zedenius J, Larsson C (2014e) Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma. J Clin Endocrinol Metab 99:E1571\u2013E1579","journal-title":"J Clin Endocrinol Metab"},{"key":"369_CR447","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1634\/theoncologist.2014-0391","volume":"20","author":"K Wang","year":"2015","unstructured":"Wang K, Liu T, Liu C, Meng Y, Yuan X, Liu L, Ge N, Liu J, Wang C, Ren H (2015) TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer. Oncologist 20:263\u2013269","journal-title":"Oncologist"},{"key":"369_CR448","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2217\/fon-2016-0414","volume":"13","author":"X Wang","year":"2017","unstructured":"Wang X, Lopez-Beltran A, Osunkoya AO, Wang M, Zhang S, Davidson DD, Emerson RE, Williamson SR, Tan PH, Kaimakliotis HZ, Baldridge LA, MacLennan GT, Montironi R, Cheng L (2017a) TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract. Future Oncol 13:705\u2013714","journal-title":"Future Oncol"},{"key":"369_CR449","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3849","volume":"49","author":"YK Wang","year":"2017","unstructured":"Wang YK, Bashashati A, Anglesio MS, Cochrane DR, Grewal DS, Ha G, McPherson A, Horlings HM, Senz J, Prentice LM, Karnezis AN, Lai D, Aniba MR, Zhang AW, Shumansky K, Siu C, Wan A, McConechy MK, Li-Chang H, Tone A, Provencher D, de Ladurantaye M, Fleury H, Okamoto A, Yanagida S, Yanaihara N, Saito M, Mungall AJ, Moore R, Marra MA, Gilks CB, Mes-Masson AM, McAlpine JN, Aparicio S, Huntsman DG, Shah SP (2017b) Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes. Nat Genet 49:856\u2013865","journal-title":"Nat Genet"},{"key":"369_CR450","doi-asserted-by":"publisher","first-page":"172","DOI":"10.21037\/hbsn.2019.09.17","volume":"10","author":"S Wang","year":"2021","unstructured":"Wang S, Shi H, Liu T, Li M, Zhou S, Qiu X, Wang Z, Hu W, Guo W, Chen X, Guo H, Shi X, Shi J, Zang Y, Cao J, Wu L (2021) Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobil Surg Nutr 10:172\u2013179","journal-title":"Hepatobil Surg Nutr"},{"key":"369_CR451","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13062","volume":"32","author":"BT Whitfield","year":"2022","unstructured":"Whitfield BT, Huse JT (2022) Classification of adult-type diffuse gliomas: impact of the World Health Organization 2021 update. Brain Pathol 32:e13062","journal-title":"Brain Pathol"},{"key":"369_CR452","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s40478-020-01040-2","volume":"8","author":"EA Williams","year":"2020","unstructured":"Williams EA, Santagata S, Wakimoto H, Shankar GM, Barker FG 2nd, Sharaf R, Reddy A, Spear P, Alexander BM, Ross JS, Brastianos PK, Cahill DP, Ramkissoon SH, Juratli TA (2020) Distinct genomic subclasses of high-grade\/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun 8:171","journal-title":"Acta Neuropathol Commun"},{"key":"369_CR453","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/modpathol.2013.68","volume":"26","author":"LD Wood","year":"2013","unstructured":"Wood LD, Heaphy CM, Daniel HD, Naini BV, Lassman CR, Arroyo MR, Kamel IR, Cosgrove DP, Boitnott JK, Meeker AK, Torbenson MS (2013) Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features. Mod Pathol 26:1586\u20131593","journal-title":"Mod Pathol"},{"key":"369_CR454","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/path.4315","volume":"232","author":"RC Wu","year":"2014","unstructured":"Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih IM, Wang TL (2014a) Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. J Pathol 232:473\u2013481","journal-title":"J Pathol"},{"key":"369_CR455","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.eururo.2013.10.038","volume":"65","author":"S Wu","year":"2014","unstructured":"Wu S, Huang P, Li C, Huang Y, Li X, Wang Y, Chen C, Lv Z, Tang A, Sun X, Lu J, Li W, Zhou J, Gui Y, Zhou F, Wang D, Cai Z (2014b) Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study. Eur Urol 65:274\u2013277","journal-title":"Eur Urol"},{"key":"369_CR456","doi-asserted-by":"publisher","first-page":"10048","DOI":"10.18632\/oncotarget.2491","volume":"5","author":"H Xie","year":"2014","unstructured":"Xie H, Liu T, Wang N, Bjornhagen V, Hoog A, Larsson C, Lui WO, Xu D (2014) TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma. Oncotarget 5:10048\u201310057","journal-title":"Oncotarget"},{"key":"369_CR457","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","volume":"32","author":"M Xing","year":"2014","unstructured":"Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J (2014) BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 32:2718\u20132726","journal-title":"J Clin Oncol"},{"key":"369_CR458","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.7150\/jca.56779","volume":"12","author":"X Xing","year":"2021","unstructured":"Xing X, Yuan X, Liu T, Dai M, Fan Y, Liu C, Str\u00e5\u00e5t K, Bj\u00f6rkholm M, Xu D (2021) Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas. J Cancer 12:3853\u20133861","journal-title":"J Cancer"},{"key":"369_CR459","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-pathol-020712-164030","volume":"8","author":"L Xu","year":"2013","unstructured":"Xu L, Li S, Stohr BA (2013a) The role of telomere biology in cancer. Annu Rev Pathol 8:49\u201378","journal-title":"Annu Rev Pathol"},{"key":"369_CR460","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2013.07.014","volume":"446","author":"M Xu","year":"2013","unstructured":"Xu M, Katzenellenbogen RA, Grandori C, Galloway DA (2013b) An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes. Virology 446:17\u201324","journal-title":"Virology"},{"key":"369_CR461","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1089\/thy.2020.0086","volume":"30","author":"B Xu","year":"2020","unstructured":"Xu B, Fuchs T, Dogan S, Landa I, Katabi N, Fagin JA, Tuttle RM, Sherman E, Gill AJ, Ghossein R (2020) Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, Immunophenotypic, and molecular study of 360 cases. Thyroid 30:1505\u20131517","journal-title":"Thyroid"},{"key":"369_CR462","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/his.14550","volume":"80","author":"B Xu","year":"2022","unstructured":"Xu B, David J, Dogan S, Landa I, Katabi N, Saliba M, Khimraj A, Sherman EJ, Tuttle RM, Tallini G, Ganly I, Fagin JA, Ghossein RA (2022) Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology 80:322\u2013337","journal-title":"Histopathology"},{"key":"369_CR463","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1089\/thy.2016.0645","volume":"27","author":"T Yabuta","year":"2017","unstructured":"Yabuta T, Matsuse M, Hirokawa M, Yamashita S, Mitsutake N, Miyauchi A (2017) TERT promoter mutations were not found in papillary thyroid microcarcinomas that showed disease progression on active surveillance. Thyroid 27:1206\u20131207","journal-title":"Thyroid"},{"key":"369_CR464","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000111132","volume":"72","author":"Y Yamamoto","year":"2007","unstructured":"Yamamoto Y, Chochi Y, Matsuyama H, Eguchi S, Kawauchi S, Furuya T, Oga A, Kang JJ, Naito K, Sasaki K (2007) Gain of 5p15.33 is associated with progression of bladder cancer. Oncology 72:132\u2013138","journal-title":"Oncology"},{"key":"369_CR465","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/neuonc\/now021","volume":"18","author":"P Yang","year":"2016","unstructured":"Yang P, Cai J, Yan W, Zhang W, Wang Y, Chen B, Li G, Li S, Wu C, Yao K, Li W, Peng X, You Y, Chen L, Jiang C, Qiu X, Jiang T, Project C (2016a) Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II\/III gliomas. Neuro-Oncology 18:1099\u20131108","journal-title":"Neuro-Oncology"},{"key":"369_CR466","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/CMR.0000000000000272","volume":"26","author":"S Yang","year":"2016","unstructured":"Yang S, Leone D, Frydenlund N, Hoang M, Deng A, Hernandez-Perez M, Biswas A, Singh R, Yaar R, Mahalingam M (2016b) Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases. Melanoma Res 26:361\u2013366","journal-title":"Melanoma Res"},{"key":"369_CR467","doi-asserted-by":"publisher","first-page":"27838","DOI":"10.18632\/oncotarget.8539","volume":"7","author":"X Yang","year":"2016","unstructured":"Yang X, Guo X, Chen Y, Chen G, Ma Y, Huang K, Zhang Y, Zhao Q, Winkler CA, An P, Lyu J (2016c) Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma. Oncotarget 7:27838\u201327847","journal-title":"Oncotarget"},{"key":"369_CR468","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2967\/jnumed.116.180240","volume":"58","author":"X Yang","year":"2017","unstructured":"Yang X, Li J, Li X, Liang Z, Gao W, Liang J, Cheng S, Lin Y (2017) TERT promoter mutation predicts radioiodine-refractory character in distant metastatic differentiated thyroid cancer. J Nucl Med 58:258\u2013265","journal-title":"J Nucl Med"},{"key":"369_CR469","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3803\/EnM.2022.1477","volume":"37","author":"H Yang","year":"2022","unstructured":"Yang H, Park H, Ryu HJ, Heo J, Kim JS, Oh YL, Choe JH, Kim JH, Kim JS, Jang HW, Kim TH, Kim SW, Chung JH (2022) Frequency of TERT promoter mutations in real-world analysis of 2,092 thyroid carcinoma patients. Endocrinol Metab (Seoul) 37:652\u2013663","journal-title":"Endocrinol Metab (Seoul)"},{"key":"369_CR470","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.humpath.2022.11.003","volume":"131","author":"S Yasir","year":"2023","unstructured":"Yasir S, Thompson S, Chen ZE, Knudson R, Knutson D, Kloft-Nelson S, Graham RP, Jain D, Simon SM, Wu TT, Torbenson M (2023) Alternative lengthening of telomeres in primary hepatic neoplasms. Hum Pathol 131:79\u201386","journal-title":"Hum Pathol"},{"key":"369_CR471","first-page":"4175","volume":"59","author":"TR Yeager","year":"1999","unstructured":"Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR (1999) Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59:4175\u20134179","journal-title":"Cancer Res"},{"key":"369_CR472","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1038\/s41467-019-10680-5","volume":"10","author":"SK Yoo","year":"2019","unstructured":"Yoo SK, Song YS, Lee EK, Hwang J, Kim HH, Jung G, Kim YA, Kim SJ, Cho SW, Won JK, Chung EJ, Shin JY, Lee KE, Kim JI, Park YJ, Seo JS (2019) Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer. Nat Commun 10:2764","journal-title":"Nat Commun"},{"key":"369_CR473","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/bjc.2015.326","volume":"113","author":"M Yoshida","year":"2015","unstructured":"Yoshida M, Ogawa R, Yoshida H, Maeshima A, Kanai Y, Kinoshita T, Hiraoka N, Sekine S (2015) TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast. Br J Cancer 113:1244\u20131248","journal-title":"Br J Cancer"},{"key":"369_CR474","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/cns.12724","volume":"23","author":"H You","year":"2017","unstructured":"You H, Wu Y, Chang K, Shi X, Chen XD, Yan W, Li R (2017) Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds. CNS Neurosci Ther 23:790\u2013797","journal-title":"CNS Neurosci Ther"},{"key":"369_CR475","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1200\/PO.20.00515","volume":"5","author":"Y Yu","year":"2021","unstructured":"Yu Y, Fan D, Song X, Zakeri K, Chen L, Kang J, McBride S, Tsai CJ, Dunn L, Sherman E, Katabi N, Dogan S, Cracchiolo J, Cohen M, Boyle JO, Lee M, Valero C, Wang J, Wong R, Morris L, Riaz N, Lee N (2021) TERT promoter mutations are enriched in oral cavity cancers and associated with locoregional recurrence. JCO Precis Oncol 5:1259","journal-title":"JCO Precis Oncol"},{"key":"369_CR476","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146803","volume":"11","author":"P Yuan","year":"2016","unstructured":"Yuan P, Cao JL, Abuduwufuer A, Wang LM, Yuan XS, Lv W, Hu J (2016a) Clinical characteristics and prognostic significance of TERT promoter mutations in cancer: a cohort study and a meta-analysis. PLoS One 11:e0146803","journal-title":"PLoS One"},{"key":"369_CR477","doi-asserted-by":"publisher","first-page":"25826","DOI":"10.18632\/oncotarget.8404","volume":"7","author":"X Yuan","year":"2016","unstructured":"Yuan X, Liu C, Wang K, Liu L, Liu T, Ge N, Kong F, Yang L, Bjorkholm M, Fan Y, Zhao S, Xu D (2016b) The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients. Oncotarget 7:25826\u201325835","journal-title":"Oncotarget"},{"key":"369_CR478","doi-asserted-by":"publisher","first-page":"23120","DOI":"10.18632\/oncotarget.15498","volume":"8","author":"X Yuan","year":"2017","unstructured":"Yuan X, Cheng G, Yu J, Zheng S, Sun C, Sun Q, Li K, Lin Z, Liu T, Li P, Xu Y, Kong F, Bjorkholm M, Xu D (2017) The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma. Oncotarget 8:23120\u201323129","journal-title":"Oncotarget"},{"key":"369_CR479","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190045","volume":"39","author":"Q Yuan","year":"2019","unstructured":"Yuan Q, Cai HQ, Zhong Y, Zhang MJ, Cheng ZJ, Hao JJ, Wang MR, Wan JH (2019) Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastoma. Biosci Rep 39:BSR20190045","journal-title":"Biosci Rep"},{"key":"369_CR480","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.07.003","volume":"493","author":"X Yuan","year":"2020","unstructured":"Yuan X, Dai M, Xu D (2020) TERT promoter mutations and GABP transcription factors in carcinogenesis: more foes than friends. Cancer Lett 493:1\u20139","journal-title":"Cancer Lett"},{"key":"369_CR481","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng.2760","volume":"45","author":"TI Zack","year":"2013","unstructured":"Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhang C-Z, Wala J, Mermel CH (2013) Pan-cancer patterns of somatic copy number alteration. Nat Genet 45:1134","journal-title":"Nat Genet"},{"key":"369_CR482","first-page":"6230","volume":"60","author":"A Zhang","year":"2000","unstructured":"Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henriksson M, Blennow E, Nordenskjold M, Zetterberg A, Bjorkholm M, Gruber A, Xu D (2000) Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res 60:6230\u20136235","journal-title":"Cancer Res"},{"key":"369_CR483","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ijc.10627","volume":"101","author":"A Zhang","year":"2002","unstructured":"Zhang A, M\u00e5n\u00e9r S, Betz R, Angstr\u00f6m T, Stendahl U, Bergman F, Zetterberg A, Wallin KL (2002) Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 101:427\u2013433","journal-title":"Int J Cancer"},{"key":"369_CR484","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41598-020-79694-0","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Shi X, Zhang J, Chen X, Zhang P, Liu A, Zhu T (2021) A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients. Sci Rep 11:387","journal-title":"Sci Rep"},{"key":"369_CR485","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/ijc.28360","volume":"134","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Gao Y, Chen Z, Hu X, Zhou F, He J (2014) Low frequency of TERT promoter somatic mutation in 313 sporadic esophageal squamous cell carcinomas. Int J Cancer 134:493\u2013494","journal-title":"Int J Cancer"},{"key":"369_CR486","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13045-014-0047-7","volume":"7","author":"X Zheng","year":"2014","unstructured":"Zheng X, Zhuge J, Bezerra SM, Faraj SF, Munari E, Fallon JT, Yang XJ, Argani P, Netto GJ, Zhong M (2014) High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. J Hematol Oncol 7:47","journal-title":"J Hematol Oncol"},{"key":"369_CR487","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3174\/ajnr.A5441","volume":"39","author":"J Zhou","year":"2018","unstructured":"Zhou J, Reddy MV, Wilson BKJ, Blair DA, Taha A, Frampton CM, Eiholzer RA, Gan PYC, Ziad F, Thotathil Z, Kirs S, Hung NA, Royds JA, Slatter TL (2018) MR imaging characteristics associate with tumor-associated macrophages in glioblastoma and provide an improved signature for survival prognostication. AJNR Am J Neuroradiol 39:252\u2013259","journal-title":"AJNR Am J Neuroradiol"},{"key":"369_CR488","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/sj.bjc.6603110","volume":"94","author":"CQ Zhu","year":"2006","unstructured":"Zhu CQ, Cutz JC, Liu N, Lau D, Shepherd FA, Squire JA, Tsao MS (2006) Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer 94:1452\u20131459","journal-title":"Br J Cancer"},{"key":"369_CR489","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/1078-0432.CCR-18-4212","volume":"26","author":"GG Zhu","year":"2020","unstructured":"Zhu GG, Nafa K, Agaram N, Zehir A, Benayed R, Sadowska J, Borsu L, Kelly C, Tap WD, Fabbri N, Athanasian E, Boland PJ, Healey JH, Berger MF, Ladanyi M, Hameed M (2020) Genomic profiling identifies association of IDH1\/IDH2 mutation with longer relapse-free and metastasis-free survival in high-grade chondrosarcoma. Clin Cancer Res 26:419\u2013427","journal-title":"Clin Cancer Res"},{"key":"369_CR490","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1134\/S0006297910130055","volume":"75","author":"MI Zvereva","year":"2011","unstructured":"Zvereva MI, Shcherbakova DM, Dontsova OA (2011) Telomerase: structure, functions, and activity regulation. Biochem Mosc 75:1563\u20131583","journal-title":"Biochem Mosc"}],"container-title":["Interdisciplinary Cancer Research","Cancer Immunology and Genetics: An Interdisciplinary Approach"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/16833_2024_369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:41:14Z","timestamp":1757119274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/16833_2024_369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031993732","9783031993749"],"references-count":490,"URL":"https:\/\/doi.org\/10.1007\/16833_2024_369","relation":{},"ISSN":["2731-4561","2731-457X"],"issn-type":[{"type":"print","value":"2731-4561"},{"type":"electronic","value":"2731-457X"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"13 October 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}